Till sidinnehåll
Kunskapsbank för cancervården Till cancercentrum.se

Referenser

Abdalla, M., Landerholm, K., Andersson, P., Andersson, R. E., & Myrelid, P. (2017). Risk of Rectal Cancer After Colectomy for Patients With Ulcerative Colitis: A National Cohort Study. Clin Gastroenterol Hepatol, 15(7), 1055-1060.e1052. doi:10.1016/j.cgh.2016.11.036

Abdel-Wahab, M. M., Wolfson, A. H., Raub, W., Landy, H., Feun, L., Sridhar, K., . . . Markoe, A. M. (1997). The role of hyperfractionated re-irradiation in metastatic brain disease: a single institutional trial. Am J Clin Oncol, 20(2), 158-160. 

Abdelli, A., Tillou, X., Alves, A., & Menahem, B. (2017). Genito-urinary sequelae after carcinological rectal resection: What to tell patients in 2017. J Visc Surg, 154(2), 93-104. doi:10.1016/j.jviscsurg.2016.10.002

Adachi, Y., Inomata, M., Miyazaki, N., Sato, K., Shiraishi, N., & Kitano, S. (1998). Distribution of lymph node metastasis and level of inferior mesenteric artery ligation in colorectal cancer. J Clin Gastroenterol, 26(3), 179-182. doi:10.1097/00004836-199804000-00006

Adamina, M., Buchs, N. C., Penna, M., & Hompes, R. (2018). St.Gallen consensus on safe implementation of transanal total mesorectal excision. Surg Endosc, 32(3), 1091-1103. doi:10.1007/s00464-017-5990-2

Adams, R. A., Meade, A. M., Seymour, M. T., Wilson, R. H., Madi, A., Fisher, D., . . . Investigators, M. C. T. (2011). Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet Oncol, 12(7), 642-653. doi:10.1016/S1470-2045(11)70102-4

Akiyoshi, T., Matsueda, K., Hiratsuka, M., Unno, T., Nagata, J., Nagasaki, T., . . . Ueno, M. (2015). Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer. Ann Surg Oncol, 22 Suppl 3, S614-620. doi:10.1245/s10434-015-4565-5

Akiyoshi, T., Ueno, M., Matsueda, K., Konishi, T., Fujimoto, Y., Nagayama, S., . . . Muto, T. (2014). Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol, 21(1), 189-196. doi:10.1245/s10434-013-3216-y

Akiyoshi, T., Watanabe, T., Miyata, S., Kotake, K., Muto, T., Sugihara, K., . . . Rectum. (2012). Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann Surg, 255(6), 1129-1134. doi:10.1097/SLA.0b013e3182565d9d

Al-Tassan, N., Chmiel, N. H., Maynard, J., Fleming, N., Livingston, A. L., Williams, G. T., . . . Cheadle, J. P. (2002). Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Nat Genet, 30(2), 227-232. doi:10.1038/ng828

Allievi, N., Ceresoli, M., Fugazzola, P., Montori, G., Coccolini, F., & Ansaloni, L. (2017). Endoscopic Stenting as Bridge to Surgery versus Emergency Resection for Left-Sided Malignant Colorectal Obstruction: An Updated Meta-Analysis. Int J Surg Oncol, 2017, 2863272. doi:10.1155/2017/2863272

Alsheridah, N., & Akhtar, S. (2018). Diet, obesity and colorectal carcinoma risk: results from a national cancer registry-based middle-eastern study. BMC Cancer, 18(1), 1227. doi:10.1186/s12885-018-5132-9

Altaf, R., Lund Brixen, A., Kristensen, B., & Nielsen, S. E. (2014). Incidence of cold-induced peripheral neuropathy and dose modification of adjuvant oxaliplatin-based chemotherapy for patients with colorectal cancer. Oncology, 87(3), 167-172. doi:10.1159/000362668

Amelung, F. J., Consten, E. C. J., Siersema, P. D., & Tanis, P. J. (2016). A Population-Based Analysis of Three Treatment Modalities for Malignant Obstruction of the Proximal Colon: Acute Resection Versus Stent or Stoma as a Bridge to Surgery. Ann Surg Oncol, 23(11), 3660-3668. doi:10.1245/s10434-016-5247-7

Amri, R., England, J., Bordeianou, L. G., & Berger, D. L. (2016). Risk Stratification in Patients with Stage II Colon Cancer. Ann Surg Oncol, 23(12), 3907-3914. doi:10.1245/s10434-016-5387-9

Andre, T., Boni, C., Navarro, M., Tabernero, J., Hickish, T., Topham, C., . . . de Gramont, A. (2009). Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol, 27(19), 3109-3116. doi:10.1200/JCO.2008.20.6771

Andre, T., Colin, P., Louvet, C., Gamelin, E., Bouche, O., Achille, E., . . . de Gramont, A. (2003). Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial. J Clin Oncol, 21(15), 2896-2903. doi:10.1200/jco.2003.10.065

Andreyev, H. J., Davidson, S. E., Gillespie, C., Allum, W. H., & Swarbrick, E. (2012). Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut, 61(2), 179-192. doi:10.1136/gutjnl-2011-300563

Antiemetika - Rekommendationer. (2017). Retrieved from http://www.regimbiblioteket.se/dokument.html

Appelt, A. L., Ploen, J., Harling, H., Jensen, F. S., Jensen, L. H., Jorgensen, J. C., . . . Jakobsen, A. (2015). High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol, 16(8), 919-927. doi:10.1016/s1470-2045(15)00120-5

Appelt, A. L., Ploen, J., Vogelius, I. R., Bentzen, S. M., & Jakobsen, A. (2013). Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys, 85(1), 74-80. doi:10.1016/j.ijrobp.2012.05.017

Arbman, G., Nilsson, E., Storgren-Fordell, V., & Sjodahl, R. (1996). A short diagnostic delay is more important for rectal cancer than for colonic cancer. Eur J Surg, 162(11), 899-904. 

Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., . . . Preiser, J. C. (2017). ESPEN guidelines on nutrition in cancer patients. Clin Nutr, 36(1), 11-48. doi:10.1016/j.clnu.2016.07.015

Arroyave, M. C., DeLacy, F. B., & Lacy, A. M. (2017). Transanal total mesorectal excision (TaTME) for rectal cancer: Step by step description of the surgical technique for a two-teams approach. Eur J Surg Oncol, 43(2), 502-505. doi:10.1016/j.ejso.2016.10.024

Astin, M., Griffin, T., Neal, R. D., Rose, P., & Hamilton, W. (2011). The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. Br J Gen Pract, 61(586), e231-243. doi:10.3399/bjgp11X572427

Atkin, W., Dadswell, E., Wooldrage, K., Kralj-Hans, I., von Wagner, C., Edwards, R., . . . Halligan, S. (2013). Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial. Lancet, 381(9873), 1194-1202. doi:10.1016/s0140-6736(12)62186-2

Bae, S. U., Hur, H., Min, B. S., Baik, S. H., Lee, K. Y., & Kim, N. K. (2018). Which Patients with Isolated Para-aortic Lymph Node Metastasis Will Truly Benefit from Extended Lymph Node Dissection for Colon Cancer? Cancer Res Treat, 50(3), 712-719. doi:10.4143/crt.2017.100

Ballard-Barbash, R., Friedenreich, C. M., Courneya, K. S., Siddiqi, S. M., McTiernan, A., & Alfano, C. M. (2012). Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst, 104(11), 815-840. doi:10.1093/jnci/djs207

Balyasnikova, S., Read, J., Tait, D., Wotherspoon, A., Swift, I., Cunningham, D., . . . Brown, G. (2017). The results of local excision with or without postoperative adjuvant chemoradiotherapy for early rectal cancer among patients choosing to avoid radical surgery. Colorectal Dis, 19(2), 139-147. doi:10.1111/codi.13477

Barn som anhöriga : konsekvenser och behov när föräldrar har allvarliga svårigheter, eller avlider. (2013). Stockholm: Socialstyrelsen.

Battersby, N. J., How, P., Moran, B., Stelzner, S., West, N. P., Branagan, G., . . . Brown, G. (2016). Prospective Validation of a Low Rectal Cancer Magnetic Resonance Imaging Staging System and Development of a Local Recurrence Risk Stratification Model: The MERCURY II Study. Ann Surg, 263(4), 751-760. doi:10.1097/sla.0000000000001193

Beets-Tan, R. G. H., Lambregts, D. M. J., Maas, M., Bipat, S., Barbaro, B., Curvo-Semedo, L., . . . Blomqvist, L. (2018). Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol, 28(4), 1465-1475. doi:10.1007/s00330-017-5026-2

Benard, F., Barkun, A. N., Martel, M., & von Renteln, D. (2018). Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarizing the current global recommendations. World J Gastroenterol, 24(1), 124-138. doi:10.3748/wjg.v24.i1.124

Bendell, J. C., Patel, M. R., Yoshida, K., Seraj, J., Weaver, R., Lemech, C., . . . Arkenau, H. T. (2016). Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors. Cancer Chemother Pharmacol, 77(6), 1275-1283. doi:10.1007/s00280-016-3031-9

Bennouna, J., Sastre, J., Arnold, D., Osterlund, P., Greil, R., Van Cutsem, E., . . . Investigators, M. L. S. (2013). Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial. Lancet Oncol, 14(1), 29-37. doi:10.1016/S1470-2045(12)70477-1

Benoist, S., Panis, Y., Denet, C., Mauvais, F., Mariani, P., & Valleur, P. (1999). Optimal duration of urinary drainage after rectal resection: a randomized controlled trial. Surgery, 125(2), 135-141. 

Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y. J., Ciombor, K. K., . . . Freedman-Cass, D. A. (2018). NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw, 16(4), 359-369. doi:10.6004/jnccn.2018.0021

Bentzen, A. G., Guren, M. G., Vonen, B., Wanderas, E. H., Frykholm, G., Wilsgaard, T., . . . Balteskard, L. (2013). Faecal incontinence after chemoradiotherapy in anal cancer survivors: long-term results of a national cohort. Radiother Oncol, 108(1), 55-60. doi:10.1016/j.radonc.2013.05.037

Bentzen, S. M., & Baumann, M. (2002). The linear-quadratic model in clinical practice. In: Steel GG (ed) . Arnold, London pp 134-146. In Basic clinical radiobiology (Steel GG ed., pp. 134-146). London: Arnold.

Bernhoff, R., Sjovall, A., Buchli, C., Granath, F., Holm, T., & Martling, A. (2018). Complete mesocolic excision in right-sided colon cancer does not increase severe short-term postoperative adverse events. Colorectal Dis, 20(5), 383-389. doi:10.1111/codi.13950

Berry, S. R., Cosby, R., Asmis, T., Chan, K., Hammad, N., Krzyzanowska, M. K., & Cancer Care Ontario's Gastrointestinal Disease Site, G. (2015). Continuous versus intermittent chemotherapy strategies in metastatic colorectal cancer: a systematic review and meta-analysis. Ann Oncol, 26(3), 477-485. doi:10.1093/annonc/mdu272

Bertelsen, C. A., Larsen, H. M., Neuenschwander, A. U., Laurberg, S., Kristensen, B., & Emmertsen, K. J. (2018). Long-term Functional Outcome After Right-Sided Complete Mesocolic Excision Compared With Conventional Colon Cancer Surgery: A Population-Based Questionnaire Study. Dis Colon Rectum, 61(9), 1063-1072. doi:10.1097/dcr.0000000000001154

Bertelsen, C. A., & Neuenschwander, A. U. (2018). The safety of complete mesocolic excision once again confirmed. Colorectal Dis, 20(6), 552. doi:10.1111/codi.13967

Bertelsen, C. A., Neuenschwander, A. U., Jansen, J. E., Kirkegaard-Klitbo, A., Tenma, J. R., Wilhelmsen, M., . . . Gogenur, I. (2016). Short-term outcomes after complete mesocolic excision compared with 'conventional' colonic cancer surgery. Br J Surg, 103(5), 581-589. doi:10.1002/bjs.10083

Bettstetter, M., Dechant, S., Ruemmele, P., Grabowski, M., Keller, G., Holinski-Feder, E., . . . Dietmaier, W. (2007). Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Clin Cancer Res, 13(11), 3221-3228. doi:10.1158/1078-0432.CCR-06-3064

Biagi, J. J., Raphael, M. J., Mackillop, W. J., Kong, W., King, W. D., & Booth, C. M. (2011). Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA, 305(22), 2335-2342. doi:10.1001/jama.2011.749

Bianco, F., Romano, G., Tsarkov, P., Stanojevic, G., Shroyer, K., Giuratrabocchetta, S., & Bergamaschi, R. (2017). Extralevator with vs nonextralevator abdominoperineal excision for rectal cancer: the RELAPe randomized controlled trial. Colorectal Dis, 19(2), 148-157. doi:10.1111/codi.13436

Birgisson, H., Pahlman, L., Gunnarsson, U., & Glimelius, B. (2005). Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol, 23(25), 6126-6131. doi:10.1200/jco.2005.02.543

Birgisson, H., Pahlman, L., Gunnarsson, U., & Glimelius, B. (2007). Late adverse effects of radiation therapy for rectal cancer - a systematic overview. Acta Oncol, 46(4), 504-516. doi:10.1080/02841860701348670

Bockelman, C., Engelmann, B. E., Kaprio, T., Hansen, T. F., & Glimelius, B. (2015). Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature. Acta Oncol, 54(1), 5-16. doi:10.3109/0284186X.2014.975839

Boeckx, N., Koukakis, R., Op de Beeck, K., Rolfo, C., Van Camp, G., Siena, S., . . . Peeters, M. (2017). Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies. Ann Oncol, 28(8), 1862-1868. doi:10.1093/annonc/mdx119

Bonadona, V., Bonaiti, B., Olschwang, S., Grandjouan, S., Huiart, L., Longy, M., . . . French Cancer Genetics, N. (2011). Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA, 305(22), 2304-2310. doi:10.1001/jama.2011.743

Bonjer, H. J., Deijen, C. L., Abis, G. A., Cuesta, M. A., van der Pas, M. H., de Lange-de Klerk, E. S., . . . Haglind, E. (2015). A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med, 372(14), 1324-1332. doi:10.1056/NEJMoa1414882

Bonjer, H. J., Hop, W. C., Nelson, H., Sargent, D. J., Lacy, A. M., Castells, A., . . . Pahlman, L. (2007). Laparoscopically assisted vs open colectomy for colon cancer: a meta-analysis. Arch Surg, 142(3), 298-303. doi:10.1001/archsurg.142.3.298

Bos, A. C., van Erning, F. N., van Gestel, Y. R., Creemers, G. J., Punt, C. J., van Oijen, M. G., & Lemmens, V. E. (2015). Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer. Eur J Cancer, 51(17), 2553-2561. doi:10.1016/j.ejca.2015.08.016

Bosch, S. L., & Nagtegaal, I. D. (2012). The Importance of the Pathologist's Role in Assessment of the Quality of the Mesorectum. Curr Colorectal Cancer Rep, 8(2), 90-98. doi:10.1007/s11888-012-0124-7

Bosset, J. F., Calais, G., Mineur, L., Maingon, P., Stojanovic-Rundic, S., Bensadoun, R. J., . . . Group, E. R. O. (2014). Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol, 15(2), 184-190. doi:10.1016/S1470-2045(13)70599-0

Bosset, J. F., Collette, L., Calais, G., Mineur, L., Maingon, P., Radosevic-Jelic, L., . . . Trial, E. R. G. (2006). Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med, 355(11), 1114-1123. doi:10.1056/NEJMoa060829

Bosset, J. F., Horiot, J. C., Hamers, H. P., Cionini, L., Bartelink, H., Caspers, R., . . . Van Glabbeke, M. (2001). Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group. Radiother Oncol, 61(1), 7-13. 

Bouchet-Doumenq, C., Lefevre, J. H., Bennis, M., Chafai, N., Tiret, E., & Parc, Y. (2016). Management of postoperative bladder emptying after proctectomy in men for rectal cancer. A retrospective study of 190 consecutive patients. Int J Colorectal Dis, 31(3), 511-518. doi:10.1007/s00384-015-2471-8

Boustani, J., Caubet, M., & Bosset, J. F. (2016). Adjuvant Chemotherapy in Rectal Cancer after Chemoradiotherapy. Clin Oncol (R Coll Radiol), 28(2), 140-145. doi:10.1016/j.clon.2015.11.004

Bradley, K. A., Rubinsky, A. D., Sun, H., Bryson, C. L., Bishop, M. J., Blough, D. K., . . . Kivlahan, D. R. (2011). Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgery. J Gen Intern Med, 26(2), 162-169. doi:10.1007/s11606-010-1475-x

Braendengen, M., Tveit, K. M., Berglund, A., Birkemeyer, E., Frykholm, G., Pahlman, L., . . . Glimelius, B. (2008). Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol, 26(22), 3687-3694. doi:10.1200/jco.2007.15.3858

Brenner, H., Altenhofen, L., Stock, C., & Hoffmeister, M. (2013). Natural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopy. Cancer Epidemiol Biomarkers Prev, 22(6), 1043-1051. doi:10.1158/1055-9965.Epi-13-0162

Breugom, A. J., van Gijn, W., Muller, E. W., Berglund, A., van den Broek, C. B., Fokstuen, T., . . . Nordic Gastrointestinal Tumour Adjuvant Therapy, G. (2015). Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial. Ann Oncol, 26(4), 696-701. doi:10.1093/annonc/mdu560

Brierley, J., Gospodarowicz, M. K., & Wittekind, C. (2017). TNM classification of malignant tumours Colon and Rectum. Chichester, West Sussex, UK ;: John Wiley & Sons, Inc.

Bruheim, K., Guren, M. G., Dahl, A. A., Skovlund, E., Balteskard, L., Carlsen, E., . . . Tveit, K. M. (2010). Sexual function in males after radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys, 76(4), 1012-1017. doi:10.1016/j.ijrobp.2009.03.075

Bruheim, K., Tveit, K. M., Skovlund, E., Balteskard, L., Carlsen, E., Fossa, S. D., & Guren, M. G. (2010). Sexual function in females after radiotherapy for rectal cancer. Acta Oncol, 49(6), 826-832. doi:10.3109/0284186x.2010.486411

Brule, S. Y., Jonker, D. J., Karapetis, C. S., O'Callaghan, C. J., Moore, M. J., Wong, R., . . . Goodwin, R. A. (2015). Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17. Eur J Cancer, 51(11), 1405-1414. doi:10.1016/j.ejca.2015.03.015

Bujko, K., Glimelius, B., Valentini, V., Michalski, W., & Spalek, M. (2015). Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery +/- a fluoropyrimidine and surgery + a fluoropyrimidine +/- oxaliplatin. Eur J Surg Oncol, 41(6), 713-723. doi:10.1016/j.ejso.2015.03.233

Bujko, K., Glynne-Jones, R., & Bujko, M. (2010). Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials. Ann Oncol, 21(9), 1743-1750. doi:10.1093/annonc/mdq054

Bujko, K., Nowacki, M. P., Nasierowska-Guttmejer, A., Michalski, W., Bebenek, M., & Kryj, M. (2006). Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg, 93(10), 1215-1223. doi:10.1002/bjs.5506

Bujko, K., Wyrwicz, L., Rutkowski, A., Malinowska, M., Pietrzak, L., Krynski, J., . . . Wydmanski, J. (2016). Long-course oxaliplatin-based preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study. Ann Oncol, 27(5), 834-842. doi:10.1093/annonc/mdw062

Burn, J., Gerdes, A. M., Macrae, F., Mecklin, J. P., Moeslein, G., Olschwang, S., . . . Investigators, C. (2011). Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet, 378(9809), 2081-2087. doi:10.1016/S0140-6736(11)61049-0

Burney, M., Purden, M., & McVey, L. (2002). Patient satisfaction and nurses' perceptions of quality in an inpatient cardiology population. J Nurs Care Qual, 16(4), 56-67; quiz 68-59. 

Burns, E. M., Currie, A., Bottle, A., Aylin, P., Darzi, A., & Faiz, O. (2013). Minimal-access colorectal surgery is associated with fewer adhesion-related admissions than open surgery. Br J Surg, 100(1), 152-159. doi:10.1002/bjs.8964

Burton, S., Brown, G., Daniels, I. R., Norman, A. R., Mason, B., Cunningham, D., & Royal Marsden Hospital, C. C. N. (2006). MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer, 94(3), 351-357. doi:10.1038/sj.bjc.6602947

Buunen, M., Veldkamp, R., Hop, W. C., Kuhry, E., Jeekel, J., Haglind, E., . . . Bonjer, H. J. (2009). Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol, 10(1), 44-52. doi:10.1016/s1470-2045(08)70310-3

Cancer prevention. Retrieved from https://www.who.int/cancer/prevention/en/

Cancer Staging Manual. Retrieved from https://cancerstaging.org/references-tools/deskreferences/pages/default.aspx

Cancerfondsrapporten 2019. Retrieved from https://www.cancerfonden.se/cancerfondsrapporten/vard

Cao, Y., Deng, S., Wu, K., Zheng, H., Cheng, P., Zhang, J., . . . Cai, K. (2019). Oncological consequence of emergent resection of perforated colon cancer with complete obstruction after stent insertion as a bridge to surgery. Int J Colorectal Dis, 34(3), 545-547. doi:10.1007/s00384-018-3137-0

Carlsson, E., Fingren, J., Hallen, A. M., Petersen, C., & Lindholm, E. (2016). The Prevalence of Ostomy-related Complications 1 Year After Ostomy Surgery: A Prospective, Descriptive, Clinical Study. Ostomy Wound Manage, 62(10), 34-48. 

Carmel, J., Colwell, J., & Goldberg, M. T. (2016). Wound, Ostomy and Continence Nurses Society core curriculum Ostomy management. Philadelphia: Wolters Kluwer.

Caron, M., Lamarre, G., Gregoire, P., Simonyan, D., & Laflamme, N. (2018). The fecal immunochemical test (fit): Selected aspects regarding its effectiveness for colorectal cancer screening in Quebec City. Prev Med Rep, 12, 6-11. doi:10.1016/j.pmedr.2018.08.003

Cavazza, A., Radia, C., Harlow, C., & Monahan, K. J. (2019). Experience of the implementation and outcomes of universal testing for Lynch syndrome in the United Kingdom. Colorectal Dis, 21(7), 760-766. doi:10.1111/codi.14597

Cawley, M. M., & Benson, L. M. (2005). Current trends in managing oral mucositis. Clin J Oncol Nurs, 9(5), 584-592. doi:10.1188/05.CJON.584-592

Cedermark, B., Johansson, H., Rutqvist, L. E., & Wilking, N. (1995). The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer, 75(9), 2269-2275. 

Chan, A. C., Poon, J. T., Fan, J. K., Lo, S. H., & Law, W. L. (2008). Impact of conversion on the long-term outcome in laparoscopic resection of colorectal cancer. Surg Endosc, 22(12), 2625-2630. doi:10.1007/s00464-008-9813-3

Chan, R. J., Larsen, E., & Chan, P. (2012). Re-examining the evidence in radiation dermatitis management literature: an overview and a critical appraisal of systematic reviews. Int J Radiat Oncol Biol Phys, 84(3), e357-362. doi:10.1016/j.ijrobp.2012.05.009

Chen, K., Cao, G., Chen, B., Wang, M., Xu, X., Cai, W., . . . Xiong, M. (2017). Laparoscopic versus open surgery for rectal cancer: A meta-analysis of classic randomized controlled trials and high-quality Nonrandomized Studies in the last 5 years. Int J Surg, 39, 1-10. doi:10.1016/j.ijsu.2016.12.123

Chen, Y., & Chi, P. (2017). [Meta-analysis of extralevator abdominoperineal excision for rectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi, 20(3), 326-332. 

Chin, C. C., Yeh, C. Y., Tang, R., Changchien, C. R., Huang, W. S., & Wang, J. Y. (2008). The oncologic benefit of high ligation of the inferior mesenteric artery in the surgical treatment of rectal or sigmoid colon cancer. Int J Colorectal Dis, 23(8), 783-788. doi:10.1007/s00384-008-0465-5

Choi, P. W., Kim, H. C., Kim, A. Y., Jung, S. H., Yu, C. S., & Kim, J. C. (2010). Extensive lymphadenectomy in colorectal cancer with isolated para-aortic lymph node metastasis below the level of renal vessels. J Surg Oncol, 101(1), 66-71. doi:10.1002/jso.21421

Cirocchi, R., Trastulli, S., Abraha, I., Vettoretto, N., Boselli, C., Montedori, A., . . . Platell, C. (2012). Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cochrane Database Syst Rev(8), Cd008997. doi:10.1002/14651858.CD008997.pub2

Clinical Outcomes of Surgical Therapy Study, G., Nelson, H., Sargent, D. J., Wieand, H. S., Fleshman, J., Anvari, M., . . . Ota, D. (2004). A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med, 350(20), 2050-2059. doi:10.1056/NEJMoa032651

Consumption of red meat and pro-cessed meat. (2015).  (Vol. 114). Lyon: International Agency for Research on Cancer. IARC Working Group.  IARC Monogr Eval Carcinog Risks Hum.

Contin, P., Kulu, Y., Bruckner, T., Sturm, M., Welsch, T., Muller-Stich, B. P., . . . Ulrich, A. (2014). Comparative analysis of late functional outcome following preoperative radiation therapy or chemoradiotherapy and surgery or surgery alone in rectal cancer. Int J Colorectal Dis, 29(2), 165-175. doi:10.1007/s00384-013-1780-z

Cormie, P., Zopf, E. M., Zhang, X., & Schmitz, K. H. (2017). The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects. Epidemiol Rev, 39(1), 71-92. doi:10.1093/epirev/mxx007

Corrigan, N., Marshall, H., Croft, J., Copeland, J., Jayne, D., & Brown, J. (2018). Exploring and adjusting for potential learning effects in ROLARR: a randomised controlled trial comparing robotic-assisted vs. standard laparoscopic surgery for rectal cancer resection. Trials, 19(1), 339. doi:10.1186/s13063-018-2726-0

Cox, J. D., Stetz, J., & Pajak, T. F. (1995). Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys, 31(5), 1341-1346. doi:10.1016/0360-3016(95)00060-c

Cremolini, C., Loupakis, F., Antoniotti, C., Lupi, C., Sensi, E., Lonardi, S., . . . Falcone, A. (2015). FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study. Lancet Oncol, 16(13), 1306-1315. doi:10.1016/s1470-2045(15)00122-9

Croner, R. S., Merkel, S., Papadopoulos, T., Schellerer, V., Hohenberger, W., & Goehl, J. (2009). Multivisceral resection for colon carcinoma. Dis Colon Rectum, 52(8), 1381-1386. doi:10.1007/DCR.0b013e3181ab580b

Cunningham, D., Pyrhonen, S., James, R. D., Punt, C. J., Hickish, T. F., Heikkila, R., . . . Herait, P. (1998). Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet, 352(9138), 1413-1418. doi:10.1016/s0140-6736(98)02309-5

Czaykowski, P. M., Gill, S., Kennecke, H. F., Gordon, V. L., & Turner, D. (2011). Adjuvant chemotherapy for stage III colon cancer: does timing matter? Dis Colon Rectum, 54(9), 1082-1089. doi:10.1097/DCR.0b013e318223c3d6

Danielsen, A. K., Park, J., Jansen, J. E., Bock, D., Skullman, S., Wedin, A., . . . Rosenberg, J. (2017). Early Closure of a Temporary Ileostomy in Patients With Rectal Cancer: A Multicenter Randomized Controlled Trial. Ann Surg, 265(2), 284-290. doi:10.1097/sla.0000000000001829

Dattani, M., Heald, R. J., Goussous, G., Broadhurst, J., Sao Juliao, G. P., Habr-Gama, A., . . . Moran, B. J. (2018). Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis. Ann Surg. doi:10.1097/sla.0000000000002761

de Gramont, A., Van Cutsem, E., Schmoll, H. J., Tabernero, J., Clarke, S., Moore, M. J., . . . Hoff, P. M. (2012). Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial. Lancet Oncol, 13(12), 1225-1233. doi:10.1016/s1470-2045(12)70509-0

de la Chapelle, A. (2005). The incidence of Lynch syndrome. Fam Cancer, 4(3), 233-237. doi:10.1007/s10689-004-5811-3

Deijen, C. L., Velthuis, S., Tsai, A., Mavroveli, S., de Lange-de Klerk, E. S., Sietses, C., . . . Bonjer, H. J. (2016). COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc, 30(8), 3210-3215. doi:10.1007/s00464-015-4615-x

Del Giudice, M. E., Vella, E. T., Hey, A., Simunovic, M., Harris, W., & Levitt, C. (2014). Systematic review of clinical features of suspected colorectal cancer in primary care. Can Fam Physician, 60(8), e405-415. 

Delhorme, J. B., Severac, F., Averous, G., Glehen, O., Passot, G., Bakrin, N., . . . Brigand, C. (2018). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin. Br J Surg, 105(6), 668-676. doi:10.1002/bjs.10716

Deng, Y., Chi, P., Lan, P., Wang, L., Chen, W., Cui, L., . . . Wang, J. (2016). Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial. J Clin Oncol, 34(27), 3300-3307. doi:10.1200/jco.2016.66.6198

Denost, Q., Adam, J. P., Rullier, A., Buscail, E., Laurent, C., & Rullier, E. (2014). Perineal transanal approach: a new standard for laparoscopic sphincter-saving resection in low rectal cancer, a randomized trial. Ann Surg, 260(6), 993-999. doi:10.1097/sla.0000000000000766

Des Guetz, G., Nicolas, P., Perret, G. Y., Morere, J. F., & Uzzan, B. (2010). Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. Eur J Cancer, 46(6), 1049-1055. doi:10.1016/j.ejca.2010.01.020

Diet, nutrition, physical activity and colorectal cancer. Continuous Update project Expert Report 2018. Retrieved from https://www.wcrf.org/dietandcancer

Digestive System Tumours. WHO Classification of Tumours, 5th Edition. WHO Classification of Tumours Editorial Board.  (Vol. 1): WHO.

Dihydropyrimidine dehydrogenase deficiency. Retrieved from https://ghr.nlm.nih.gov/condition/dihydropyrimidine-dehydrogenase-deficiency

Dossa, F., Chesney, T. R., Acuna, S. A., & Baxter, N. N. (2017). A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol, 2(7), 501-513. doi:10.1016/s2468-1253(17)30074-2

Douillard, J. Y., Cunningham, D., Roth, A. D., Navarro, M., James, R. D., Karasek, P., . . . Rougier, P. (2000). Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet, 355(9209), 1041-1047. 

Douillard, J. Y., Oliner, K. S., Siena, S., Tabernero, J., Burkes, R., Barugel, M., . . . Patterson, S. D. (2013). Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med, 369(11), 1023-1034. doi:10.1056/NEJMoa1305275

Dulskas, A., Smolskas, E., Kildusiene, I., & Samalavicius, N. E. (2018). Treatment possibilities for low anterior resection syndrome: a review of the literature. Int J Colorectal Dis, 33(3), 251-260. doi:10.1007/s00384-017-2954-x

Dumont, F., Kothodinis, K., Goere, D., Honore, C., Dartigues, P., Boige, V., . . . Elias, D. (2012). Central retroperitoneal recurrences from colorectal cancer: are lymph node and locoregional recurrences the same disease? Eur J Surg Oncol, 38(7), 611-616. doi:10.1016/j.ejso.2012.04.003

Dunberger, G., & Bergmark, K. (2012). Nurse-led care for the management of side effects of pelvic radiotherapy: what does it achieve? Curr Opin Support Palliat Care, 6(1), 60-68. doi:10.1097/SPC.0b013e32834f6a95

Ehrenpreis, E. D., Marsh, R. d. W., & Small Jr, W. (2015). Radiation Therapy for Pelvic Malignancy and its Consequences [Elektronisk resurs]. New York, NY: Springer New York :.

Ekbom, A., Helmick, C., Zack, M., & Adami, H. O. (1990). Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet, 336(8711), 357-359. 

Elez, E., Argiles, G., & Tabernero, J. (2015). First-Line Treatment of Metastatic Colorectal Cancer: Interpreting FIRE-3, PEAK, and CALGB/SWOG 80405. Curr Treat Options Oncol, 16(11), 52. doi:10.1007/s11864-015-0369-x

Elias, D., Gilly, F., Boutitie, F., Quenet, F., Bereder, J. M., Mansvelt, B., . . . Glehen, O. (2010). Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol, 28(1), 63-68. doi:10.1200/JCO.2009.23.9285

En nationell cancerstrategi för framtiden SOU 2009:11. 

Enblad, M., Graf, W., & Birgisson, H. (2018). Risk factors for appendiceal and colorectal peritoneal metastases. European Journal of Surgical Oncology, 44(7), 997-1005. doi:https://doi.org/10.1016/j.ejso.2018.02.245

Erlandsson, J., Holm, T., Pettersson, D., Berglund, A., Cedermark, B., Radu, C., . . . Martling, A. (2017). Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol, 18(3), 336-346. doi:10.1016/s1470-2045(17)30086-4

Erlandsson, J., & Martling, A. (2017). Short-course radiotherapy with delayed surgery for rectal cancer - Authors' reply. Lancet Oncol, 18(6), e295. doi:10.1016/s1470-2045(17)30323-6

ESMO Clinical Practice Guidelines: Gastrointestinal Cancers. Retrieved from https://www.esmo.org/Guidelines/Gastrointestinal-Cancers

Evaluation of Genomic Applications in, P., & Prevention Working, G. (2009). Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med, 11(1), 35-41. doi:10.1097/GIM.0b013e31818fa2ff

Evans, J., Bhoday, J., Sizer, B., Tekkis, P., Swift, R., Perez, R., . . . Brown, G. (2016). Results of a prospective randomised control 6 vs 12 trial: Is greater tumour downstaging observed on post treatment MRI if surgery is delayed to 12-weeks versus 6-weeks after completion of neoadjuvant chemoradiotherapy? Annals of Oncology, 27(suppl_6). doi:10.1093/annonc/mdw370.01 %J Annals of Oncology

Ewing, M., Naredi, P., Zhang, C., & Mansson, J. (2016). Identification of patients with non-metastatic colorectal cancer in primary care: a case-control study. Br J Gen Pract, 66(653), e880-e886. doi:10.3399/bjgp16X687985

Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. (1992). J Clin Oncol, 10(6), 904-911. doi:10.1200/jco.1992.10.6.904

Falcone, A., Ricci, S., Brunetti, I., Pfanner, E., Allegrini, G., Barbara, C., . . . Gruppo Oncologico Nord, O. (2007). Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol, 25(13), 1670-1676. doi:10.1200/JCO.2006.09.0928

Farrington, S. M., Tenesa, A., Barnetson, R., Wiltshire, A., Prendergast, J., Porteous, M., . . . Dunlop, M. G. (2005). Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet, 77(1), 112-119. doi:10.1086/431213

Feddern, M. L., Emmertsen, K. J., & Laurberg, S. (2015). Life with a stoma after curative resection for rectal cancer: a population-based cross-sectional study. Colorectal Dis, 17(11), 1011-1017. doi:10.1111/codi.13041

Feight, D., Baney, T., Bruce, S., & McQuestion, M. (2011). Putting evidence into practice. Clin J Oncol Nurs, 15(5), 481-492. doi:10.1188/11.Cjon.481-492

Figueredo, A., Coombes, M. E., & Mukherjee, S. (2008). Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev(3), CD005390. doi:10.1002/14651858.CD005390.pub2

Fingren, J., Lindholm, E., & Carlsson, E. (2013). Perceptions of phantom rectum syndrome and health-related quality of life in patients following abdominoperineal resection for rectal cancer. J Wound Ostomy Continence Nurs, 40(3), 280-286. doi:10.1097/WON.0b013e31827e8b20

Fleshman, J., Branda, M., Sargent, D. J., Boller, A. M., George, V., Abbas, M., . . . Nelson, H. (2015). Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. JAMA, 314(13), 1346-1355. doi:10.1001/jama.2015.10529

Folkesson, J., Birgisson, H., Pahlman, L., Cedermark, B., Glimelius, B., & Gunnarsson, U. (2005). Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol, 23(24), 5644-5650. doi:10.1200/jco.2005.08.144

Forbes, L. J., Simon, A. E., Warburton, F., Boniface, D., Brain, K. E., Dessaix, A., . . . International Cancer Benchmarking Partnership Module 2 Working, G. (2013). Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival? Br J Cancer, 108(2), 292-300. doi:10.1038/bjc.2012.542

Forsberg, A. M., Kjellstrom, L., Agreus, L., Nixon Andreasson, A., Nyhlin, H., Talley, N. J., & Bjorck, E. (2012). Prevalence of colonic neoplasia and advanced lesions in the normal population: a prospective population-based colonoscopy study. Scand J Gastroenterol, 47(2), 184-190. doi:10.3109/00365521.2011.647062

Frasson, M., Garcia-Granero, E., Parajo, A., Garcia-Mayor, L., Flor, B., Garcia-Granero, A., & Lavery, I. (2015). Rectal cancer threatening or affecting the prostatic plane: is partial prostatectomy oncologically adequate? Results of a multicentre retrospective study. Colorectal Dis, 17(8), 689-697. doi:10.1111/codi.12933

Frykholm, G. J., Glimelius, B., & Pahlman, L. (1993). Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum, 36(6), 564-572. 

Fujita, S., Mizusawa, J., Kanemitsu, Y., Ito, M., Kinugasa, Y., Komori, K., . . . Colorectal Cancer Study Group of Japan Clinical Oncology, G. (2017). Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial. Ann Surg, 266(2), 201-207. doi:10.1097/SLA.0000000000002212

Fujita, S., Yamamoto, S., Akasu, T., & Moriya, Y. (2012). Prognostic factors of rectal cancer patients with lateral pelvic lymph node metastasis. Hepatogastroenterology, 59(120), 2494-2497. doi:10.5754/hge12153

Gagniere, J., Dupre, A., Chabaud, S., Peyrat, P., Meeus, P., & Rivoire, M. (2015). Retroperitoneal nodal metastases from colorectal cancer: Curable metastases with radical retroperitoneal lymphadenectomy in selected patients. Eur J Surg Oncol, 41(6), 731-737. doi:10.1016/j.ejso.2015.03.229

Gao, P., Huang, X. Z., Song, Y. X., Sun, J. X., Chen, X. W., Sun, Y., . . . Wang, Z. N. (2018). Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study. BMC Cancer, 18(1), 234. doi:10.1186/s12885-018-4138-7

Garcia-Aguilar, J., Shi, Q., Thomas, C. R., Jr., Chan, E., Cataldo, P., Marcet, J., . . . Posner, M. C. (2012). A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol, 19(2), 384-391. doi:10.1245/s10434-011-1933-7

Gasbarrini, A., Lauritano, E. C., Gabrielli, M., Scarpellini, E., Lupascu, A., Ojetti, V., & Gasbarrini, G. (2007). Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis, 25(3), 237-240. doi:10.1159/000103892

Gatta, L., & Scarpignato, C. (2017). Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther, 45(5), 604-616. doi:10.1111/apt.13928

The GEC ESTRO Handbook of Brachytherapy. Retrieved from https://user-swndwmf.cld.bz/Rectal-Cancer-GEC-ESTRO-Handbook-of-Brachytherapy/14#4

Gelsomino, F., Barbolini, M., Spallanzani, A., Pugliese, G., & Cascinu, S. (2016). The evolving role of microsatellite instability in colorectal cancer: A review. Cancer Treat Rev, 51, 19-26. doi:10.1016/j.ctrv.2016.10.005

Gerard, J. P., Conroy, T., Bonnetain, F., Bouche, O., Chapet, O., Closon-Dejardin, M. T., . . . Bedenne, L. (2006). Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol, 24(28), 4620-4625. doi:10.1200/jco.2006.06.7629

Ghazal, A. H., El-Shazly, W. G., Bessa, S. S., El-Riwini, M. T., & Hussein, A. M. (2013). Colonic endolumenal stenting devices and elective surgery versus emergency subtotal/total colectomy in the management of malignant obstructed left colon carcinoma. J Gastrointest Surg, 17(6), 1123-1129. doi:10.1007/s11605-013-2152-2

Gibor, U., Perry, Z., Tirosh, D., Netz, U., Rosental, A., Fich, A., . . . Kirshtein, B. (2017). Comparison of the Long-Term Oncological Outcomes of Stent as a Bridge to Surgery and Surgery Alone in Malignant Colonic Obstruction. Isr Med Assoc J, 19(12), 736-740. 

Gill, S., Loprinzi, C. L., Sargent, D. J., Thome, S. D., Alberts, S. R., Haller, D. G., . . . Goldberg, R. M. (2004). Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol, 22(10), 1797-1806. doi:10.1200/JCO.2004.09.059

Gillis, C., Fenton, T. R., Sajobi, T. T., Minnella, E. M., Awasthi, R., Loiselle, S. E., . . . Carli, F. (2019). Trimodal prehabilitation for colorectal surgery attenuates post-surgical losses in lean body mass: A pooled analysis of randomized controlled trials. Clin Nutr, 38(3), 1053-1060. doi:10.1016/j.clnu.2018.06.982

Glimelius, B., & Cavalli-Bjorkman, N. (2012). Metastatic colorectal cancer: current treatment and future options for improved survival. Medical approach--present status. Scand J Gastroenterol, 47(3), 296-314. doi:10.3109/00365521.2012.640828

Glimelius, B., Isacsson, U., Jung, B., & Pahlman, L. (1997). Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose-response effect favoring preoperative treatment. Int J Radiat Oncol Biol Phys, 37(2), 281-287. 

Glimelius, B., Myklebust, T. A., Lundqvist, K., Wibe, A., & Guren, M. G. (2016). Two countries - Two treatment strategies for rectal cancer. Radiother Oncol, 121(3), 357-363. doi:10.1016/j.radonc.2016.11.010

Glynne-Jones, R., & Hughes, R. (2012). Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation. Br J Surg, 99(7), 897-909. doi:10.1002/bjs.8732

Glynne-Jones, R., Wyrwicz, L., Tiret, E., Brown, G., Rodel, C., Cervantes, A., & Arnold, D. (2017). Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 28(suppl_4), iv22-iv40. doi:10.1093/annonc/mdx224

Gollins, S., Moran, B., Adams, R., Cunningham, C., Bach, S., Myint, A. S., . . . Geh, I. (2017). Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) - Multidisciplinary Management. Colorectal Dis, 19 Suppl 1, 37-66. doi:10.1111/codi.13705

Gonzalez, E., Holm, K., Wennstrom, B., Haglind, E., & Angenete, E. (2016). Self-reported wellbeing and body image after abdominoperineal excision for rectal cancer. Int J Colorectal Dis, 31(10), 1711-1717. doi:10.1007/s00384-016-2628-0

Gorissen, K. J., Tuynman, J. B., Fryer, E., Wang, L., Uberoi, R., Jones, O. M., . . . Lindsey, I. (2013). Local recurrence after stenting for obstructing left-sided colonic cancer. Br J Surg, 100(13), 1805-1809. doi:10.1002/bjs.9297

Gouvas, N., Agalianos, C., Papaparaskeva, K., Perrakis, A., Hohenberger, W., & Xynos, E. (2016). Surgery along the embryological planes for colon cancer: a systematic review of complete mesocolic excision. Int J Colorectal Dis, 31(9), 1577-1594. doi:10.1007/s00384-016-2626-2

Grace, E., Shaw, C., Whelan, K., & Andreyev, H. J. (2013). Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther, 38(7), 674-688. doi:10.1111/apt.12456

Gray, R., Barnwell, J., McConkey, C., Hills, R. K., Williams, N. S., & Kerr, D. J. (2007). Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet, 370(9604), 2020-2029. doi:10.1016/s0140-6736(07)61866-2

Grothey, A., Sobrero, A. F., Shields, A. F., Yoshino, T., Paul, J., Taieb, J., . . . Iveson, T. (2018). Duration of Adjuvant Chemotherapy for Stage III Colon Cancer. N Engl J Med, 378(13), 1177-1188. doi:10.1056/NEJMoa1713709

Guillou, P. J., Quirke, P., Thorpe, H., Walker, J., Jayne, D. G., Smith, A. M., . . . group, M. C. t. (2005). Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet, 365(9472), 1718-1726. doi:10.1016/S0140-6736(05)66545-2

Gupta, A., Muls, A. C., Lalji, A., Thomas, K., Watson, L., Shaw, C., & Andreyev, H. J. (2015). Outcomes from treating bile acid malabsorption using a multidisciplinary approach. Support Care Cancer, 23(10), 2881-2890. doi:10.1007/s00520-015-2653-5

Guren, M. G., Undseth, C., Rekstad, B. L., Braendengen, M., Dueland, S., Spindler, K. L., . . . Tveit, K. M. (2014). Reirradiation of locally recurrent rectal cancer: a systematic review. Radiother Oncol, 113(2), 151-157. doi:10.1016/j.radonc.2014.11.021

Gustafsson, P., Jestin, P., Gunnarsson, U., & Lindforss, U. (2015). Higher frequency of anastomotic leakage with stapled compared to hand-sewn ileocolic anastomosis in a large population-based study. World J Surg, 39(7), 1834-1839. doi:10.1007/s00268-015-2996-6

Gustafsson, U. O., Scott, M. J., Hubner, M., Nygren, J., Demartines, N., Francis, N., . . . Ljungqvist, O. (2019). Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS((R))) Society Recommendations: 2018. World J Surg, 43(3), 659-695. doi:10.1007/s00268-018-4844-y

Haddock, M. G., Gunderson, L. L., Nelson, H., Cha, S. S., Devine, R. M., Dozois, R. R., & Wolff, B. G. (2001). Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients. Int J Radiat Oncol Biol Phys, 49(5), 1267-1274. doi:10.1016/s0360-3016(00)01528-5

Hafström, L., Naredi, P., & Glimelius, B. (2013). Mag-tarmkanalens cancersjukdomar. Lund: Studentlitteratur.

Haggitt, R. C., Glotzbach, R. E., Soffer, E. E., & Wruble, L. D. (1985). Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology, 89(2), 328-336. 

Haller, D. G., Catalano, P. J., Macdonald, J. S., O'Rourke, M. A., Frontiera, M. S., Jackson, D. V., & Mayer, R. J. (2005). Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. J Clin Oncol, 23(34), 8671-8678. doi:10.1200/jco.2004.00.5686

Haller, D. G., Tabernero, J., Maroun, J., de Braud, F., Price, T., Van Cutsem, E., . . . Schmoll, H. J. (2011). Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol, 29(11), 1465-1471. doi:10.1200/JCO.2010.33.6297

Halvarsson, B., Muller, W., Planck, M., Benoni, A. C., Mangell, P., Ottosson, J., . . . Nilbert, M. (2007). Phenotypic heterogeneity in hereditary non-polyposis colorectal cancer: identical germline mutations associated with variable tumour morphology and immunohistochemical expression. J Clin Pathol, 60(7), 781-786. doi:10.1136/jcp.2006.040402

Hamberger, B., & Haglund, U. (2017). Kirurgi. Stockholm: Liber.

Hamilton, W., Green, T., Martins, T., Elliott, K., Rubin, G., & Macleod, U. (2013). Evaluation of risk assessment tools for suspected cancer in general practice: a cohort study. Br J Gen Pract, 63(606), e30-36. doi:10.3399/bjgp13X660751

Hamilton, W., Lancashire, R., Sharp, D., Peters, T. J., Cheng, K., & Marshall, T. (2009). The risk of colorectal cancer with symptoms at different ages and between the sexes: a case-control study. BMC Med, 7, 17. doi:10.1186/1741-7015-7-17

Hammarstrom, K., Mezheyeuski, A., Korsavidou Hult, N., Sjoblom, T., & Glimelius, B. (2018). Stage distribution utilizing magnetic resonance imaging in an unselected population of primary rectal cancers. Eur J Surg Oncol, 44(12), 1858-1864. doi:10.1016/j.ejso.2018.07.063

Hansson, L.-E. (2013). Akut buk : diagnostik och behandling av akut buksmärta. Lund: Studentlitteratur.

Hashiguchi, Y., Hase, K., Ueno, H., Mochizuki, H., Shinto, E., & Yamamoto, J. (2011). Optimal margins and lymphadenectomy in colonic cancer surgery. Br J Surg, 98(8), 1171-1178. doi:10.1002/bjs.7518

Hegewisch-Becker, S., Graeven, U., Lerchenmuller, C. A., Killing, B., Depenbusch, R., Steffens, C. C., . . . Arnold, D. (2015). Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol, 16(13), 1355-1369. doi:10.1016/s1470-2045(15)00042-x

Heinemann, V., von Weikersthal, L. F., Decker, T., Kiani, A., Vehling-Kaiser, U., Al-Batran, S. E., . . . Stintzing, S. (2014). FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. Lancet Oncol, 15(10), 1065-1075. doi:10.1016/S1470-2045(14)70330-4

Hellbom, M., & Thomé, B. (2011). Perspektiv på onkologisk vård. Lund: Studentlitteratur.

Hida, J., Okuno, K., Yasutomi, M., Yoshifuji, T., Uchida, T., Tokoro, T., & Shiozaki, H. (2005). Optimal ligation level of the primary feeding artery and bowel resection margin in colon cancer surgery: the influence of the site of the primary feeding artery. Dis Colon Rectum, 48(12), 2232-2237. doi:10.1007/s10350-005-0161-2

Hippisley-Cox, J., & Coupland, C. (2012). Identifying patients with suspected colorectal cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract, 62(594), e29-37. doi:10.3399/bjgp12X616346

Ho, K. S., Quah, H. M., Lim, J. F., Tang, C. L., & Eu, K. W. (2012). Endoscopic stenting and elective surgery versus emergency surgery for left-sided malignant colonic obstruction: a prospective randomized trial. Int J Colorectal Dis, 27(3), 355-362. doi:10.1007/s00384-011-1331-4

Hofheinz, R. D., Wenz, F., Post, S., Matzdorff, A., Laechelt, S., Hartmann, J. T., . . . Hochhaus, A. (2012). Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol, 13(6), 579-588. doi:10.1016/s1470-2045(12)70116-x

Hohenberger, W., Weber, K., Matzel, K., Papadopoulos, T., & Merkel, S. (2009). Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. Colorectal Dis, 11(4), 354-364; discussion 364-355. doi:10.1111/j.1463-1318.2008.01735.x

Holch, J. W., Ricard, I., Stintzing, S., Modest, D. P., & Heinemann, V. (2017). The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials. Eur J Cancer, 70, 87-98. doi:10.1016/j.ejca.2016.10.007

Hollinworth, H., & Mann, L. (2010). Managing acute skin reactions to radiotherapy treatment. Nurs Stand, 24(24), 53-54, 56, 58 passim. doi:10.7748/ns2010.02.24.24.53.c7558

Holm, S., & Hansen, E. (2000). Pre- och postoperativ omvårdnad. Lund: Studentlitteratur.

Hong, Y. S., Kim, S. Y., Lee, J. S., Nam, B.-H., Kim, J. E., Kim, K.-P., . . . Kim, T. W. (2018). Long-term results of the ADORE trial: Adjuvant oxaliplatin, leucovorin, and 5-fluorouracil (FOLFOX) versus 5-fluorouracil and leucovorin (FL) after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer. 36(15_suppl), 3501-3501. doi:10.1200/JCO.2018.36.15_suppl.3501

Huang, C. Q., Min, Y., Wang, S. Y., Yang, X. J., Liu, Y., Xiong, B., . . . Li, Y. (2017). Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence. Oncotarget, 8(33), 55657-55683. doi:10.18632/oncotarget.17497

Hussan, H., Clinton, S. K., Roberts, K., & Bailey, M. T. (2017). Fusobacterium's link to colorectal neoplasia sequenced: A systematic review and future insights. World J Gastroenterol, 23(48), 8626-8650. doi:10.3748/wjg.v23.i48.8626

Hutchins, G., Southward, K., Handley, K., Magill, L., Beaumont, C., Stahlschmidt, J., . . . Quirke, P. (2011). Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol, 29(10), 1261-1270. doi:10.1200/JCO.2010.30.1366

. IARC Handbooks of Cancer Prevention. IARC Working Group on the Evaluation of Cancer-Preventive Interventions. (2019). In Colorectal cancer screening. Lyon (FR): International Agency for Research on Cancer.

Ihemelandu, C., Fernandez, S., & Sugarbaker, P. H. (2017). A Prognostic Model for Predicting Overall Survival in Patients with Peritoneal Surface Malignancy of an Appendiceal Origin Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol, 24(8), 2266-2272. doi:10.1245/s10434-017-5847-x

Införande av allmän tarmcancerscreening. Slutrapport och rekommendation. Version 1.0 (2018). Retrieved from https://www.cancercentrum.se/globalassets/vara-uppdrag/prevention-tidig-upptackt/tarmcancerscreening/slutrapport_inforande_tarmcancerscreening_18-02-28.pdf

Inoue, Y., Saigusa, S., Hiro, J., Toiyama, Y., Araki, T., Tanaka, K., . . . Kusunoki, M. (2016). Clinical significance of enlarged lateral pelvic lymph nodes before and after preoperative chemoradiotherapy for rectal cancer. Mol Clin Oncol, 4(6), 994-1002. doi:10.3892/mco.2016.855

Ishihara, S., Kawai, K., Tanaka, T., Kiyomatsu, T., Hata, K., Nozawa, H., . . . Watanabe, T. (2017). Oncological Outcomes of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated With Preoperative Chemoradiotherapy. Dis Colon Rectum, 60(5), 469-476. doi:10.1097/DCR.0000000000000752

Itagaki, R., Koda, K., Yamazaki, M., Shuto, K., Kosugi, C., Hirano, A., . . . Suzuki, M. (2014). Serotonin (5-HT3) receptor antagonists for the reduction of symptoms of low anterior resection syndrome. Clin Exp Gastroenterol, 7, 47-52. doi:10.2147/ceg.S55410

Iwakawa, M., Noda, S., Yamada, S., Yamamoto, N., Miyazawa, Y., Yamazaki, H., . . . Imai, T. (2006). Analysis of non-genetic risk factors for adverse skin reactions to radiotherapy among 284 breast cancer patients. Breast Cancer, 13(3), 300-307. 

Iversen, L. H., Antonsen, S., Laurberg, S., & Lautrup, M. D. (2009). Therapeutic delay reduces survival of rectal cancer but not of colonic cancer. Br J Surg, 96(10), 1183-1189. doi:10.1002/bjs.6700

Iveson, T. J., Kerr, R. S., Saunders, M. P., Cassidy, J., Hollander, N. H., Tabernero, J., . . . Paul, J. (2018). 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial. Lancet Oncol, 19(4), 562-578. doi:10.1016/s1470-2045(18)30093-7

Jagsi, R., Griffith, K. A., Koelling, T., Roberts, R., & Pierce, L. J. (2007). Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer. Cancer, 109(4), 650-657. doi:10.1002/cncr.22452

Jayne, D., Pigazzi, A., Marshall, H., Croft, J., Corrigan, N., Copeland, J., . . . Brown, J. (2017). Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial. JAMA, 318(16), 1569-1580. doi:10.1001/jama.2017.7219

Jayne, D. G., Thorpe, H. C., Copeland, J., Quirke, P., Brown, J. M., & Guillou, P. J. (2010). Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg, 97(11), 1638-1645. doi:10.1002/bjs.7160

Je, Y., Jeon, J. Y., Giovannucci, E. L., & Meyerhardt, J. A. (2013). Association between physical activity and mortality in colorectal cancer: a meta-analysis of prospective cohort studies. Int J Cancer, 133(8), 1905-1913. doi:10.1002/ijc.28208

Jeffery, M., Hickey, B. E., & Hider, P. N. (2007). Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev(1), CD002200. doi:10.1002/14651858.CD002200.pub2

Jellema, P., van der Windt, D. A., Bruinvels, D. J., Mallen, C. D., van Weyenberg, S. J., Mulder, C. J., & de Vet, H. C. (2010). Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis. BMJ, 340, c1269. doi:10.1136/bmj.c1269

Jeong, S. Y., Park, J. W., Nam, B. H., Kim, S., Kang, S. B., Lim, S. B., . . . Oh, J. H. (2014). Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol, 15(7), 767-774. doi:10.1016/S1470-2045(14)70205-0

Jess, T., Simonsen, J., Jorgensen, K. T., Pedersen, B. V., Nielsen, N. M., & Frisch, M. (2012). Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology, 143(2), 375-381.e371; quiz e313-374. doi:10.1053/j.gastro.2012.04.016

Jestin, P., Pahlman, L., Glimelius, B., & Gunnarsson, U. (2005). Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination. Eur J Cancer, 41(14), 2071-2078. doi:10.1016/j.ejca.2005.06.012

Jimenez, W., Sardi, A., Nieroda, C., Sittig, M., Milovanov, V., Nunez, M., . . . Gushchin, V. (2014). Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol, 21(13), 4218-4225. doi:10.1245/s10434-014-3869-1

Johansson, A. C., Brink, E., Cliffordson, C., & Axelsson, M. (2018). The function of fatigue and illness perceptions as mediators between self-efficacy and health-related quality of life during the first year after surgery in persons treated for colorectal cancer. J Clin Nurs, 27(7-8), e1537-e1548. doi:10.1111/jocn.14300

Jones, H. J. S., Goodbrand, S., Hompes, R., Mortensen, N., & Cunningham, C. (2019). Radiotherapy after local excision of rectal cancer may offer reduced local recurrence rates. Colorectal Dis, 21(4), 451-459. doi:10.1111/codi.14546

Jones, K. R., Burney, R. E., & Christy, B. (2000). Patient expectations for surgery: are they being met? Jt Comm J Qual Improv, 26(6), 349-360. 

Jonker, D. J., Spithoff, K., Maroun, J., & Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based, C. (2011). Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline. Clin Oncol (R Coll Radiol), 23(5), 314-322. doi:10.1016/j.clon.2011.02.010

Kanas, G. P., Taylor, A., Primrose, J. N., Langeberg, W. J., Kelsh, M. A., Mowat, F. S., . . . Poston, G. (2012). Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol, 4, 283-301. doi:10.2147/clep.S34285

Kang, S. B., Park, J. W., Jeong, S. Y., Nam, B. H., Choi, H. S., Kim, D. W., . . . Oh, J. H. (2010). Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol, 11(7), 637-645. doi:10.1016/S1470-2045(10)70131-5

Kannarkatt, J., Joseph, J., Kurniali, P. C., Al-Janadi, A., & Hrinczenko, B. (2017). Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma. J Oncol Pract, 13(4), 233-241. doi:10.1200/jop.2016.017210

Kanso, F., Lefevre, J. H., Svrcek, M., Chafai, N., Parc, Y., & Tiret, E. (2016). Partial Mesorectal Excision for Rectal Adenocarcinoma: Morbidity and Oncological Outcome. Clin Colorectal Cancer, 15(1), 82-90.e81. doi:10.1016/j.clcc.2015.07.008

Kapiteijn, E., Marijnen, C. A., Nagtegaal, I. D., Putter, H., Steup, W. H., Wiggers, T., . . . Dutch Colorectal Cancer, G. (2001). Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med, 345(9), 638-646. doi:10.1056/NEJMoa010580

Kaufman, E. L., Jacobson, J. S., Hershman, D. L., Desai, M., & Neugut, A. I. (2008). Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol, 26(3), 392-398. doi:10.1200/JCO.2007.13.3033

Kehlet, H., & Wilmore, D. W. (2008). Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg, 248(2), 189-198. doi:10.1097/SLA.0b013e31817f2c1a

Kendal, W. S., & Nicholas, G. (2007). A population-based analysis of second primary cancers after irradiation for rectal cancer. Am J Clin Oncol, 30(4), 333-339. doi:10.1097/01.coc.0000258084.55036.9e

Keulers, B. J., Scheltinga, M. R., Houterman, S., Van Der Wilt, G. J., & Spauwen, P. H. (2008). Surgeons underestimate their patients' desire for preoperative information. World J Surg, 32(6), 964-970. doi:10.1007/s00268-008-9581-1

Kikuchi, R., Takano, M., Takagi, K., Fujimoto, N., Nozaki, R., Fujiyoshi, T., & Uchida, Y. (1995). Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum, 38(12), 1286-1295. 

Kim, B. C. (2016). Comparison of a Subtotal Colectomy With Self-Expandable Metallic Stent in the Management of Patients With Obstructive Left Colon Cancer. Ann Coloproctol, 32(6), 203-204. doi:10.3393/ac.2016.32.6.203

Kim, J. C., Takahashi, K., Yu, C. S., Kim, H. C., Kim, T. W., Ryu, M. H., . . . Mori, T. (2007). Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Ann Surg, 246(5), 754-762. doi:10.1097/SLA.0b013e318070d587

Kim, M. J., Chan Park, S., Kim, T. H., Kim, D. Y., Kim, S. Y., Baek, J. Y., . . . Oh, J. H. (2016). Is lateral pelvic node dissection necessary after preoperative chemoradiotherapy for rectal cancer patients with initially suspected lateral pelvic node? Surgery, 160(2), 366-376. doi:10.1016/j.surg.2016.04.006

Kim, M. J., Hur, B. Y., Lee, E. S., Park, B., Joo, J., Kim, M. J., . . . Oh, J. H. (2018). Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings. PLoS One, 13(4), e0195815. doi:10.1371/journal.pone.0195815

Kim, M. J., Kim, T. H., Kim, D. Y., Kim, S. Y., Baek, J. Y., Chang, H. J., . . . Oh, J. H. (2015). Can chemoradiation allow for omission of lateral pelvic node dissection for locally advanced rectal cancer? J Surg Oncol, 111(4), 459-464. doi:10.1002/jso.23852

Kim, T. G., Park, W., Choi, D. H., Park, H. C., Kim, S. H., Cho, Y. B., . . . Chun, H. K. (2014). Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients. Int J Colorectal Dis, 29(2), 193-200. doi:10.1007/s00384-013-1797-3

Kim, T. H., Jeong, S. Y., Choi, D. H., Kim, D. Y., Jung, K. H., Moon, S. H., . . . Park, J. G. (2008). Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol, 15(3), 729-737. 

Kim, T. W., Shen, L., Xu, J. M., Sriuranpong, V., Pan, H., Xu, R., . . . Li, J. (2016). TERRA: a randomized, double-blind, placebo-controlled phase 3 study of TAS-102 in Asian patients with metastatic colorectal cancer. Annals of Oncology, 27(suppl_6). doi:10.1093/annonc/mdw370.14 %J Annals of Oncology

Klarskov, L., Holck, S., Bernstein, I., & Nilbert, M. (2012). Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome. J Clin Pathol, 65(4), 352-356. doi:10.1136/jclinpath-2011-200535

Komborozos, V. A., Skrekas, G. J., & Pissiotis, C. A. (2001). The contribution of follow-up programs in the reduction of mortality of rectal cancer recurrences. Dig Surg, 18(5), 403-408. 

Komen, M. M., Smorenburg, C. H., van den Hurk, C. J., & Nortier, J. W. (2013). Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist, 18(7), 885-891. doi:10.1634/theoncologist.2012-0332

Kompetensbeskrivning legitimerad sjuksköterska med specialisering inom stomiterapi. (2017). Retrieved from https://www.swenurse.se/Sa-tycker-vi/publikationer/Kompetensbeskrivningar-och-riktlinjer/legitimerad-sjukskoterska-med-specialisering-inom-stomiterapi/

Kontaktsjuksköterskan. Retrieved from https://www.cancercentrum.se/samverkan/patient-och-narstaende/kontaktsjukskoterska/

Koopman, M., Antonini, N. F., Douma, J., Wals, J., Honkoop, A. H., Erdkamp, F. L., . . . Punt, C. J. (2007). Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet, 370(9582), 135-142. doi:10.1016/S0140-6736(07)61086-1

Korsgaard, M., Pedersen, L., Sorensen, H. T., & Laurberg, S. (2006). Delay of treatment is associated with advanced stage of rectal cancer but not of colon cancer. Cancer Detect Prev, 30(4), 341-346. doi:10.1016/j.cdp.2006.07.001

Kuebler, J. P., Wieand, H. S., O'Connell, M. J., Smith, R. E., Colangelo, L. H., Yothers, G., . . . Wolmark, N. (2007). Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol, 25(16), 2198-2204. doi:10.1200/JCO.2006.08.2974

Kuijpers, A. M., Mirck, B., Aalbers, A. G., Nienhuijs, S. W., de Hingh, I. H., Wiezer, M. J., . . . Verwaal, V. J. (2013). Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol. Ann Surg Oncol, 20(13), 4224-4230. doi:10.1245/s10434-013-3145-9

Kumar, A., Kennecke, H. F., Renouf, D. J., Lim, H. J., Gill, S., Woods, R., . . . Cheung, W. Y. (2015). Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer. Cancer, 121(4), 527-534. doi:10.1002/cncr.29072

Kumar, S., Juresic, E., Barton, M., & Shafiq, J. (2010). Management of skin toxicity during radiation therapy: a review of the evidence. J Med Imaging Radiat Oncol, 54(3), 264-279. doi:10.1111/j.1754-9485.2010.02170.x

Kusters, M., Slater, A., Muirhead, R., Hompes, R., Guy, R. J., Jones, O. M., . . . Cunningham, C. (2017). What To Do With Lateral Nodal Disease in Low Locally Advanced Rectal Cancer? A Call for Further Reflection and Research. Dis Colon Rectum, 60(6), 577-585. doi:10.1097/DCR.0000000000000834

Kwakman, J. J. M., Simkens, L. H. J., van Rooijen, J. M., van de Wouw, A. J., Ten Tije, A. J., Creemers, G. J. M., . . . Punt, C. J. A. (2017). Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group. Ann Oncol, 28(6), 1288-1293. doi:10.1093/annonc/mdx122

Labianca, R., Nordlinger, B., Beretta, G. D., Mosconi, S., Mandala, M., Cervantes, A., & Arnold, D. (2013). Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 24 Suppl 6, vi64-72. doi:10.1093/annonc/mdt354

Lagerstedt-Robinson, K., Rohlin, A., Aravidis, C., Melin, B., Nordling, M., Stenmark-Askmalm, M., . . . Nilbert, M. (2016). Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population. Oncol Rep, 36(5), 2823-2835. doi:10.3892/or.2016.5060

Lange, M. M., Maas, C. P., Marijnen, C. A., Wiggers, T., Rutten, H. J., Kranenbarg, E. K., & van de Velde, C. J. (2008). Urinary dysfunction after rectal cancer treatment is mainly caused by surgery. Br J Surg, 95(8), 1020-1028. doi:10.1002/bjs.6126

Law, W. L., Chu, K. W., Ho, J. W., Tung, H. M., Law, S. Y., & Chu, K. M. (2000). Self-expanding metallic stent in the treatment of colonic obstruction caused by advanced malignancies. Dis Colon Rectum, 43(11), 1522-1527. doi:10.1007/bf02236731

Le, D. T., Kavan, P., Kim, T. W., Burge, M. E., Cutsem, E. V., Hara, H., . . . O'Neil, B. H. (2018). KEYNOTE-164: Pembrolizumab for patients with advanced microsatellite instability high (MSI-H) colorectal cancer. 36(15_suppl), 3514-3514. doi:10.1200/JCO.2018.36.15_suppl.3514

Le, D. T., Kim, T. W., Van Cutsem, E., Geva, R., Jager, D., Hara, H., . . . Andre, T. (2020). Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164. J Clin Oncol, 38(1), 11-19. doi:10.1200/jco.19.02107

Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., . . . Diaz, L. A., Jr. (2015). PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med, 372(26), 2509-2520. doi:10.1056/NEJMoa1500596

Lee, Y. J., Yoon, J. Y., Park, J. J., Park, S. J., Kim, J. H., Youn, Y. H., . . . Cheon, J. H. (2018). Clinical outcomes and factors related to colonic perforations in patients receiving self-expandable metal stent insertion for malignant colorectal obstruction. Gastrointest Endosc, 87(6), 1548-1557.e1541. doi:10.1016/j.gie.2018.02.006

Lefevre, J. H., Mineur, L., Kotti, S., Rullier, E., Rouanet, P., de Chaisemartin, C., . . . Tiret, E. (2016). Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6). J Clin Oncol, 34(31), 3773-3780. doi:10.1200/jco.2016.67.6049

Lenz, H. J., Stintzing, S., & Loupakis, F. (2015). TAS-102, a novel antitumor agent: a review of the mechanism of action. Cancer Treat Rev, 41(9), 777-783. doi:10.1016/j.ctrv.2015.06.001

Lesniewski-Kmak, K., Moiseenko, V., Saunders, M., Wasan, H., Argiles, G., Borg, C., . . . Van Cutsem, E. (2018). Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer (mCRC) patients who are non-eligible for intensive therapy (TASCO1): Results of the primary analysis. Ann Oncol, 29 Suppl 5, v108. doi:10.1093/annonc/mdy149.021

Lesniewski-Kmak, K., Moiseenko, V., Saunders, MP., et al. Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer who are non-eligible for intensive therapy (TASCO1): results of the primary analysis. Paper presented at the ESMO GI. 2018;O-013. . 

Liang, P. S., Chen, T. Y., & Giovannucci, E. (2009). Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer, 124(10), 2406-2415. doi:10.1002/ijc.24191

Limit red and processed meat. Eat no more than moderate amounts of red meat and little, if any, processed meat. Retrieved from https://www.wcrf.org/dietandcancer/recommendations/limit-red-processed-meat

Lindholm, E., Brevinge, H., & Haglind, E. (2008). Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg, 95(8), 1029-1036. doi:10.1002/bjs.6136

Litner M, Z. T., & T, Z. (1998). Does preoperative information increase the wellbeing of the patient after surgery? 18: 31–33, 39. In Vård i Norden (Vol. 18).

Lordan, J. T., Karanjia, N. D., Quiney, N., Fawcett, W. J., & Worthington, T. R. (2009). A 10-year study of outcome following hepatic resection for colorectal liver metastases - The effect of evaluation in a multidisciplinary team setting. Eur J Surg Oncol, 35(3), 302-306. doi:10.1016/j.ejso.2008.01.028

Loughrey, M. B., Quirke, P., & Shepherd, N. A. (2017). Standards and datasets for reporting cancers. Dataset for colorectal cancer histopathology reports. . 

Loupakis, F., Cremolini, C., Masi, G., Lonardi, S., Zagonel, V., Salvatore, L., . . . Falcone, A. (2014). Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer. N Engl J Med, 371(17), 1609-1618. doi:10.1056/NEJMoa1403108

Low anterior resection syndrome (LARS) - Regionalt vårdprogram. Retrieved from https://www.cancercentrum.se/contentassets/8b4c20d30df942e9b7056786e586c6aa/lars--regionalt-vardprogram.pdf

Lu, H. J., Lin, J. K., Chen, W. S., Jiang, J. K., Yang, S. H., Lan, Y. T., . . . Teng, H. W. (2015). The Prognostic Role of Para-Aortic Lymph Nodes in Patients with Colorectal Cancer: Is It Regional or Distant Disease? PLoS One, 10(6), e0130345. doi:10.1371/journal.pone.0130345

Lund, C. M., Nielsen, D., Dehlendorff, C., Christiansen, A. B., Ronholt, F., Johansen, J. S., & Vistisen, K. K. (2016). Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colorectal cancer: the ACCORE study. ESMO Open, 1(5), e000087. doi:10.1136/esmoopen-2016-000087

Luo, D., Liu, Q., Yu, W., Ma, Y., Zhu, J., Lian, P., . . . Li, X. (2018). Prognostic value of distant metastasis sites and surgery in stage IV colorectal cancer: a population-based study. Int J Colorectal Dis, 33(9), 1241-1249. doi:10.1007/s00384-018-3091-x

Lykke, J., Rosenberg, J., Jess, P., & Roikjaer, O. (2019). Lymph node yield and tumour subsite are associated with survival in stage I-III colon cancer: results from a national cohort study. World J Surg Oncol, 17(1), 62. doi:10.1186/s12957-019-1604-x

Lynch, H. T., Lynch, P. M., Lanspa, S. J., Snyder, C. L., Lynch, J. F., & Boland, C. R. (2009). Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet, 76(1), 1-18. doi:10.1111/j.1399-0004.2009.01230.x

Lynge, E., Tornberg, S., von Karsa, L., Segnan, N., & van Delden, J. J. (2012). Determinants of successful implementation of population-based cancer screening programmes. Eur J Cancer, 48(5), 743-748. doi:10.1016/j.ejca.2011.06.051

Ma, B., Gao, P., Song, Y., Zhang, C., Zhang, C., Wang, L., . . . Wang, Z. (2016). Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer, 16, 380. doi:10.1186/s12885-016-2428-5

Ma, B., Ren, Y., Chen, Y., Lian, B., Jiang, P., Li, Y., . . . Meng, Q. (2019). Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery? A systematic review and meta-analysis. Int J Colorectal Dis, 34(1), 113-121. doi:10.1007/s00384-018-3181-9

Maas, M., Beets-Tan, R. G., Lambregts, D. M., Lammering, G., Nelemans, P. J., Engelen, S. M., . . . Beets, G. L. (2011). Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol, 29(35), 4633-4640. doi:10.1200/jco.2011.37.7176

MacBride, S. K., Wells, M. E., Hornsby, C., Sharp, L., Finnila, K., & Downie, L. (2008). A case study to evaluate a new soft silicone dressing, Mepilex Lite, for patients with radiation skin reactions. Cancer Nurs, 31(1), E8-14. doi:10.1097/01.Ncc.0000305680.06143.39

MacDermid, E., Hooton, G., MacDonald, M., McKay, G., Grose, D., Mohammed, N., & Porteous, C. (2009). Improving patient survival with the colorectal cancer multi-disciplinary team. Colorectal Dis, 11(3), 291-295. doi:10.1111/j.1463-1318.2008.01580.x

Macdonald, G., Kondor, N., Yousefi, V., Green, A., Wong, F., & Aquino-Parsons, C. (2004). Reduction of carboxyhaemoglobin levels in the venous blood of cigarette smokers following the administration of carbogen. Radiother Oncol, 73(3), 367-371. doi:10.1016/j.radonc.2004.09.002

Martin, S. T., Heneghan, H. M., & Winter, D. C. (2012). Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg, 99(7), 918-928. doi:10.1002/bjs.8702

Martinez-Perez, A., Carra, M. C., Brunetti, F., & de'Angelis, N. (2017). Pathologic Outcomes of Laparoscopic vs Open Mesorectal Excision for Rectal Cancer: A Systematic Review and Meta-analysis. JAMA Surg, 152(4), e165665. doi:10.1001/jamasurg.2016.5665

Martling, A., Smedby, K. E., Birgisson, H., Olsson, H., Granath, F., Ekbom, A., & Glimelius, B. (2017). Risk of second primary cancer in patients treated with radiotherapy for rectal cancer. Br J Surg, 104(3), 278-287. doi:10.1002/bjs.10327

Masi, G., Vasile, E., Loupakis, F., Cupini, S., Fornaro, L., Baldi, G., . . . Falcone, A. (2011). Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis. J Natl Cancer Inst, 103(1), 21-30. doi:10.1093/jnci/djq456

Matsuda, T., Sumi, Y., Yamashita, K., Hasegawa, H., Yamamoto, M., Matsuda, Y., . . . Kakeji, Y. (2018). Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis, 33(4), 367-374. doi:10.1007/s00384-018-2974-1

Matthiessen, A., Folkesson, J., Hallböök, O., Hjern, F., Mangell, P., Olsson, H., . . . Tiefenthal, M. (2018). Dynamiskt decennium för svensk kolorektal laparoskopi. Svensk kirurgi, 76(6), 54-56. 

Mayer, R. J., Van Cutsem, E., Falcone, A., Yoshino, T., Garcia-Carbonero, R., Mizunuma, N., . . . Ohtsu, A. (2015). Randomized trial of TAS-102 for refractory metastatic colorectal cancer. N Engl J Med, 372(20), 1909-1919. doi:10.1056/NEJMoa1414325

McCarty, T. R., Bazarbashi, A. N., Hathorn, K. E., Thompson, C. C., & Aihara, H. (2019). Endoscopic submucosal dissection (ESD) versus transanal endoscopic microsurgery (TEM) for treatment of rectal tumors: a comparative systematic review and meta-analysis. Surg Endosc. doi:10.1007/s00464-019-06945-1

McDonald, J. R., O'Dwyer, S. T., Rout, S., Chakrabarty, B., Sikand, K., Fulford, P. E., . . . Renehan, A. G. (2012). Classification of and cytoreductive surgery for low-grade appendiceal mucinous neoplasms. Br J Surg, 99(7), 987-992. doi:10.1002/bjs.8739

McLaughlin, C., Kim, N. K., Bandyopadhyay, D., Deng, X., Kaplan, B., Matin, K., & Fields, E. C. (2019). Adjuvant radiation therapy for T4 non-rectal colon adenocarcinoma provides a cause-specific survival advantage: A SEER database analysis. Radiother Oncol, 133, 50-53. doi:10.1016/j.radonc.2018.11.026

Menahem, B., Lubrano, J., Vallois, A., & Alves, A. (2018). Early Closure of Defunctioning Loop Ileostomy: Is It Beneficial for the Patient? A Meta-analysis. World J Surg, 42(10), 3171-3178. doi:10.1007/s00268-018-4603-0

Merkel, S., Wein, A., Gunther, K., Papadopoulos, T., Hohenberger, W., & Hermanek, P. (2001). High-risk groups of patients with Stage II colon carcinoma. Cancer, 92(6), 1435-1443. 

Min, B. S., Kim, J. S., Kim, N. K., Lim, J. S., Lee, K. Y., Cho, C. H., & Sohn, S. K. (2009). Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis. Ann Surg Oncol, 16(12), 3271-3278. doi:10.1245/s10434-009-0692-1

Minnella, E. M., & Carli, F. (2018). Prehabilitation and functional recovery for colorectal cancer patients. Eur J Surg Oncol, 44(7), 919-926. doi:10.1016/j.ejso.2018.04.016

Modest, D. P., Stintzing, S., von Weikersthal, L. F., Decker, T., Kiani, A., Vehling-Kaiser, U., . . . Heinemann, V. (2017). Exploring the effect of primary tumor sidedness on therapeutic efficacy across treatment lines in patients with metastatic colorectal cancer: analysis of FIRE-3 (AIOKRK0306). Oncotarget, 8(62), 105749-105760. doi:10.18632/oncotarget.22396

Mogal, H., Chouliaras, K., Levine, E. A., Shen, P., & Votanopoulos, K. I. (2016). Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes. J Gastrointest Oncol, 7(1), 129-142. doi:10.3978/j.issn.2078-6891.2015.131

Mohiuddin, M., Marks, G., & Marks, J. (2002). Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer, 95(5), 1144-1150. doi:10.1002/cncr.10799

Molecular testing strategies for Lynch syndrome in people with colorectal cancer. (2017). Retrieved from https://www.nice.org.uk/guidance/dg27/resources

Moller, P., Seppala, T., Bernstein, I., Holinski-Feder, E., Sala, P., Evans, D. G., . . . Mallorca, G. (2017). Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut, 66(3), 464-472. doi:10.1136/gutjnl-2015-309675

Mols, F., Beijers, T., Lemmens, V., van den Hurk, C. J., Vreugdenhil, G., & van de Poll-Franse, L. V. (2013). Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol, 31(21), 2699-2707. doi:10.1200/JCO.2013.49.1514

Monahan, K. J., Bradshaw, N., Dolwani, S., Desouza, B., Dunlop, M. G., East, J. E., . . . Hill, J. (2020). Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG). Gut, 69(3), 411-444. doi:10.1136/gutjnl-2019-319915

Morikawa, E., Yasutomi, M., Shindou, K., Matsuda, T., Mori, N., Hida, J., . . . et al. (1994). Distribution of metastatic lymph nodes in colorectal cancer by the modified clearing method. Dis Colon Rectum, 37(3), 219-223. doi:10.1007/bf02048158

Muller, S., Zalunardo, M. P., Hubner, M., Clavien, P. A., Demartines, N., & Zurich Fast Track Study, G. (2009). A fast-track program reduces complications and length of hospital stay after open colonic surgery. Gastroenterology, 136(3), 842-847. doi:10.1053/j.gastro.2008.10.030

Munro, A., Brown, M., Niblock, P., Steele, R., & Carey, F. (2015). Do Multidisciplinary Team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience. BMC Cancer, 15, 686. doi:10.1186/s12885-015-1683-1

Myerson, R. J., Garofalo, M. C., El Naqa, I., Abrams, R. A., Apte, A., Bosch, W. R., . . . Kachnic, L. A. (2009). Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys, 74(3), 824-830. doi:10.1016/j.ijrobp.2008.08.070

Nakai, N., Yamaguchi, T., Kinugasa, Y., Shiomi, A., Kagawa, H., Yamakawa, Y., . . . Furutani, A. (2017). Long-term outcomes after resection of para-aortic lymph node metastasis from left-sided colon and rectal cancer. Int J Colorectal Dis, 32(7), 999-1007. doi:10.1007/s00384-017-2806-8

Nasvall, P., Dahlstrand, U., Lowenmark, T., Rutegard, J., Gunnarsson, U., & Strigard, K. (2017). Quality of life in patients with a permanent stoma after rectal cancer surgery. Qual Life Res, 26(1), 55-64. doi:10.1007/s11136-016-1367-6

Nath, B., Li, Y., Carroll, J. E., Szabo, G., Tseng, J. F., & Shah, S. A. (2010). Alcohol exposure as a risk factor for adverse outcomes in elective surgery. J Gastrointest Surg, 14(11), 1732-1741. doi:10.1007/s11605-010-1350-4

Nathorst-Boos, J., von Schoultz, B., & Carlstrom, K. (1993). Elective ovarian removal and estrogen replacement therapy--effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol, 14(4), 283-293. 

Nationella kvalitetsregisterrapporter för tjock- och ändtarmscancer. Retrieved from https://www.cancercentrum.se/samverkan/cancerdiagnoser/tjocktarm-andtarm-och-anal/tjock--och-andtarm/kvalitetsregister/rapporter/

Nationella kvalitetsregisterrapporter Tjock- och Ändtarmscancer. Retrieved from https://cancercentrum.se/samverkan/cancerdiagnoser/tjocktarm-andtarm-och-anal/tjock--och-andtarm/kvalitetsregister/rapporter/

Nationella riktlinjer för återbesök efter tarm-och stomioperation. (2017). Retrieved from https://www.sskr.nu/files/2018-03/5.12-nationella-riktlinjer-fo-r-a-terbeso-k-efter-stomiopearationriitta-2016-1-.pdf

Nationella vårdprogrammet för cancerrehabilitering. Retrieved from https://www.cancercentrum.se/samverkan/vara-uppdrag/cancerrehabilitering/vardprogram/

Nedkylning av hårbotten för att förhindra håravall i samband med cytostatikabehandling. SBU Alert-rapport nr 2005-06. ISSN 1652-7151. (2005). Retrieved from https://www.sbu.se/sv/publikationer/SBU-utvarderar/nedkylning-av-harbotten-for-att-forhindra-haravfall-i-samband-med-cytostatikabehandling/

Neri, E., Halligan, S., Hellstrom, M., Lefere, P., Mang, T., Regge, D., . . . Laghi, A. (2013). The second ESGAR consensus statement on CT colonography. Eur Radiol, 23(3), 720-729. doi:10.1007/s00330-012-2632-x

Ng, M., Leong, T., Chander, S., Chu, J., Kneebone, A., Carroll, S., . . . Kachnic, L. (2012). Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer. Int J Radiat Oncol Biol Phys, 83(5), 1455-1462. doi:10.1016/j.ijrobp.2011.12.058

Ngan, S. Y., Burmeister, B., Fisher, R. J., Solomon, M., Goldstein, D., Joseph, D., . . . Mackay, J. (2012). Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol, 30(31), 3827-3833. doi:10.1200/jco.2012.42.9597

Nicholson, B. D., Shinkins, B., Pathiraja, I., Roberts, N. W., James, T. J., Mallett, S., . . . Mant, D. (2015). Blood CEA levels for detecting recurrent colorectal cancer. Cochrane Database Syst Rev(12), Cd011134. doi:10.1002/14651858.CD011134.pub2

Nijkamp, J., Marijnen, C., van Herk, M., van Triest, B., & Sonke, J. J. (2012). Adaptive radiotherapy for long course neo-adjuvant treatment of rectal cancer. Radiother Oncol, 103(3), 353-359. doi:10.1016/j.radonc.2012.02.013

Nijkamp, J., Swellengrebel, M., Hollmann, B., de Jong, R., Marijnen, C., van Vliet-Vroegindeweij, C., . . . Sonke, J. J. (2012). Repeat CT assessed CTV variation and PTV margins for short- and long-course pre-operative RT of rectal cancer. Radiother Oncol, 102(3), 399-405. doi:10.1016/j.radonc.2011.11.011

Nikoletti, S., Hyde, S., Shaw, T., Myers, H., & Kristjanson, L. J. (2005). Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil. J Clin Nurs, 14(6), 750-753. doi:10.1111/j.1365-2702.2005.01156.x

Nilsson, P. J., van Etten, B., Hospers, G. A., Pahlman, L., van de Velde, C. J., Beets-Tan, R. G., . . . Glimelius, B. (2013). Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial. BMC Cancer, 13, 279. doi:10.1186/1471-2407-13-279

Nitsche, U., Stoss, C., Stecher, L., Wilhelm, D., Friess, H., & Ceyhan, G. O. (2018). Meta-analysis of outcomes following resection of the primary tumour in patients presenting with metastatic colorectal cancer. Br J Surg, 105(7), 784-796. doi:10.1002/bjs.10682

Nivåstrukturerad cancervård – för patienternas bästa. En rapport från uppdraget om nationell samordning av delar av den högspecialiserade cancervården. Sveriges Kommuner och Landsting. 11 september 2013. ISBN 978–91–7164–977–5. http://www.socialstyrelsen.se/SiteCollectionDocuments/slutrapport–ns–20130910.pdf 

Nya läkemedel vid gastrointestinal cancer: Gastrointestinal Onkologisk Förenings (GOFs) värdering av klinisk nytta 2017 (2017). Retrieved from http://onkologi.org/wp-content/uploads/2014/11/GOFGuideFinal170213.pdf

O'Connell, M. J., Laurie, J. A., Kahn, M., Fitzgibbons, R. J., Jr., Erlichman, C., Shepherd, L., . . . Figueredo, A. (1998). Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol, 16(1), 295-300. doi:10.1200/jco.1998.16.1.295

O'Connell, M. J., Mailliard, J. A., Kahn, M. J., Macdonald, J. S., Haller, D. G., Mayer, R. J., & Wieand, H. S. (1997). Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol, 15(1), 246-250. doi:10.1200/jco.1997.15.1.246

O'Connor, E. S., Greenblatt, D. Y., LoConte, N. K., Gangnon, R. E., Liou, J. I., Heise, C. P., & Smith, M. A. (2011). Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol, 29(25), 3381-3388. doi:10.1200/JCO.2010.34.3426

Ogura, A., Akiyoshi, T., Takatsu, Y., Nagata, J., Nagasaki, T., Konishi, T., . . . Ueno, M. (2017). The significance of extended lymphadenectomy for colorectal cancer with isolated synchronous extraregional lymph node metastasis. Asian J Surg, 40(4), 254-261. doi:10.1016/j.asjsur.2015.10.003

Ogura, A., Konishi, T., Cunningham, C., Garcia-Aguilar, J., Iversen, H., Toda, S., . . . Lateral Node Study, C. (2019). Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer. J Clin Oncol, 37(1), 33-43. doi:10.1200/JCO.18.00032

Oh, H. K., Kang, S. B., Lee, S. M., Lee, S. Y., Ihn, M. H., Kim, D. W., . . . Park, K. J. (2014). Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study. Ann Surg Oncol, 21(7), 2280-2287. doi:10.1245/s10434-014-3559-z

Oien, K., Forsmo, H. M., Rosler, C., Nylund, K., Waage, J. E., & Pfeffer, F. (2019). Endorectal ultrasound and magnetic resonance imaging for staging of early rectal cancers: how well does it work in practice? Acta Oncol, 58(sup1), S49-s54. doi:10.1080/0284186x.2019.1569259

Oistamo, E., Hjern, F., Blomqvist, L., Falken, Y., Pekkari, K., & Abraham-Nordling, M. (2016). Emergency management with resection versus proximal stoma or stent treatment and planned resection in malignant left-sided colon obstruction. World J Surg Oncol, 14(1), 232. doi:10.1186/s12957-016-0994-2

Oliphant, R., Czerniewski, A., Robertson, I., McNulty, C., Waterston, A., & Macdonald, A. (2015). The Effect of Adjuvant Chemotherapy on Stoma-Related Complications After Surgery for Colorectal Cancer: A Retrospective Analysis. J Wound Ostomy Continence Nurs, 42(5), 494-498. doi:10.1097/won.0000000000000171

Olofsson, F., Buchwald, P., Elmstahl, S., & Syk, I. (2016). No benefit of extended mesenteric resection with central vascular ligation in right-sided colon cancer. Colorectal Dis, 18(8), 773-778. doi:10.1111/codi.13305

Olofsson, F., Buchwald, P., Elmstahl, S., & Syk, I. (2019). High Tie or not in Resection for Cancer in the Sigmoid Colon? Scand J Surg, 108(3), 227-232. doi:10.1177/1457496918812198

Onkologirapport 2017 från Svenska Koloncancerregistret. (2019). Retrieved from https://cancercentrum.se/globalassets/cancerdiagnoser/tjock--och-andtarm-anal/kvalitetsregister/tjock-och-andtarm-fr.-2018/onkologirapport2017.pdf

OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients. Retrieved from https://clinicaltrials.gov/ct2/show/NCT02005562

Osterman, E., & Glimelius, B. (2018). Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population. Dis Colon Rectum, 61(9), 1016-1025. doi:10.1097/dcr.0000000000001158

Overman, M. J., Lonardi, S., Wong, K. Y. M., Lenz, H. J., Gelsomino, F., Aglietta, M., . . . Andre, T. (2018). Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. J Clin Oncol, 36(8), 773-779. doi:10.1200/jco.2017.76.9901

Overman, M. J., McDermott, R., Leach, J. L., Lonardi, S., Lenz, H. J., Morse, M. A., . . . Andre, T. (2017). Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol, 18(9), 1182-1191. doi:10.1016/s1470-2045(17)30422-9

Pai, R. K., Beck, A. H., Norton, J. A., & Longacre, T. A. (2009). Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Am J Surg Pathol, 33(10), 1425-1439. doi:10.1097/PAS.0b013e3181af6067

Pakkiforlob for kraeft i tyk- og endetarm. Retrieved from https://www.sst.dk/-/media/Udgivelser/2019/Pakkeforloeb-kraeft-2015-2019/Tyk-endetarm-2016/Pakkeforl%C3%B8b-for-kr%C3%A6ft-i-tyk--og-endetarm-%E2%80%93-revision-sep-2016_endelig.ashx?la=da&hash=60D0965295EF48701F87F6135A97CE281B00A898

Palmer, G., Martling, A., Cedermark, B., & Holm, T. (2011). Preoperative tumour staging with multidisciplinary team assessment improves the outcome in locally advanced primary rectal cancer. Colorectal Dis, 13(12), 1361-1369. doi:10.1111/j.1463-1318.2010.02460.x

Papadimitriou, C. A., Papakostas, P., Karina, M., Malettou, L., Dimopoulos, M. A., Pentheroudakis, G., . . . Fountzilas, G. (2011). A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study. BMC Med, 9, 10. doi:10.1186/1741-7015-9-10

Park, J. S., Choi, G. S., Kim, S. H., Kim, H. R., Kim, N. K., Lee, K. Y., . . . Kang, H. (2013). Multicenter analysis of risk factors for anastomotic leakage after laparoscopic rectal cancer excision: the Korean laparoscopic colorectal surgery study group. Ann Surg, 257(4), 665-671. doi:10.1097/SLA.0b013e31827b8ed9

Park, J. S., Chon, H. J., Jeung, H. C., Shin, S. J., Rha, S. Y., Ahn, J. B., . . . Chung, H. C. (2016). High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer. J Cancer Res Clin Oncol, 142(9), 2051-2059. doi:10.1007/s00432-016-2208-2

Parodi, A., De Ceglie, A., De Luca, L., Conigliaro, R., Naspetti, R., Arpe, P., . . . Conio, M. (2016). Endoscopic stenting as bridge-to-surgery (BTS) in left-sided obstructing colorectal cancer: Experience with conformable stents. Clin Res Hepatol Gastroenterol, 40(5), 638-644. doi:10.1016/j.clinre.2016.03.007

Parry, S., Win, A. K., Parry, B., Macrae, F. A., Gurrin, L. C., Church, J. M., . . . Jenkins, M. A. (2011). Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut, 60(7), 950-957. doi:10.1136/gut.2010.228056

Peeters, M., Price, T. J., Cervantes, A., Sobrero, A. F., Ducreux, M., Hotko, Y., . . . Sidhu, R. (2014). Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer. Ann Oncol, 25(1), 107-116. doi:10.1093/annonc/mdt523

Penna, M., Hompes, R., Arnold, S., Wynn, G., Austin, R., Warusavitarne, J., . . . Tekkis, P. P. (2017). Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases. Ann Surg, 266(1), 111-117. doi:10.1097/sla.0000000000001948

Penna, M., Hompes, R., Arnold, S., Wynn, G., Austin, R., Warusavitarne, J., . . . Tekkis, P. P. (2018). Incidence and Risk Factors for Anastomotic Failure in 1594 Patients Treated by Transanal Total Mesorectal Excision: Results From the International TaTME Registry. Ann Surg. doi:10.1097/sla.0000000000002653

Perrakis, A., Juratli, T. A., Hohenberger, W., Croner, R. S., & Schackert, G. (2016). [Surgery for metastases, anatomical and ethical limits. Special aspect: oligometastases]. Chirurg, 87(3), 208-215. doi:10.1007/s00104-015-0147-0

Person, B., Ifargan, R., Lachter, J., Duek, S. D., Kluger, Y., & Assalia, A. (2012). The impact of preoperative stoma site marking on the incidence of complications, quality of life, and patient's independence. Dis Colon Rectum, 55(7), 783-787. doi:10.1097/DCR.0b013e31825763f0

Persson, E., Berndtsson, I., & Carlsson, E. (2008). Stomi- och tarmopererad : ett helhetsperspektiv. Lund: Studentlitteratur.

Persson, E., Berndtsson, I., Carlsson, E., Hallen, A. M., & Lindholm, E. (2010). Stoma-related complications and stoma size - a 2-year follow up. Colorectal Dis, 12(10), 971-976. doi:10.1111/j.1463-1318.2009.01941.x

Petersson, J., Koedam, T. W., Bonjer, H. J., Andersson, J., Angenete, E., Bock, D., . . . Haglind, E. (2019). Bowel Obstruction and Ventral Hernia After Laparoscopic Versus Open Surgery for Rectal Cancer in A Randomized Trial (COLOR II). Ann Surg, 269(1), 53-57. doi:10.1097/sla.0000000000002790

Pettersson, D., Lorinc, E., Holm, T., Iversen, H., Cedermark, B., Glimelius, B., & Martling, A. (2015). Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer. Br J Surg, 102(8), 972-978; discussion 978. doi:10.1002/bjs.9811

Pettersson, M. E., Ohlen, J., Friberg, F., Hyden, L. C., Wallengren, C., Sarenmalm, E. K., & Carlsson, E. (2018). Prepared for surgery - Communication in nurses' preoperative consultations with patients undergoing surgery for colorectal cancer after a person-centred intervention. J Clin Nurs, 27(13-14), 2904-2916. doi:10.1111/jocn.14312

Pfeiffer, P., Yilmaz, M., Möller, S., Maltha, L., Krogh, M., Zitnjak, D., . . . Qvortrup, C. (2019). Randomized study evaluating trifluridine/tipiracil (TAS-102) versus + trifluridine/tipiracil + bevacizumab as last-line therapy in patients with chemorefractory unresectable metastatic colorectal cancer (mCRC). 37(4_suppl), 637-637. doi:10.1200/JCO.2019.37.4_suppl.637

Phelip, J. M., Molinie, F., Delafosse, P., Launoy, G., Tretarre, B., Bara, S., . . . Faivre, J. (2010). A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers. Gastroenterol Clin Biol, 34(2), 144-149. doi:10.1016/j.gcb.2009.08.012

Phipps, A. I., Shi, Q., Zemla, T. J., Dotan, E., Gill, S., Goldberg, R. M., . . . Alberts, S. R. (2018). Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance). Cancer Epidemiol Biomarkers Prev, 27(6), 696-703. doi:10.1158/1055-9965.Epi-17-0769

Pimentel-Nunes, P., Dinis-Ribeiro, M., Ponchon, T., Repici, A., Vieth, M., De Ceglie, A., . . . Deprez, P. H. (2015). Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy, 47(9), 829-854. doi:10.1055/s-0034-1392882

Plastaras, J. P., Dionisi, F., & Wo, J. Y. (2014). Gastrointestinal cancer: nonliver proton therapy for gastrointestinal cancers. Cancer J, 20(6), 378-386. doi:10.1097/ppo.0000000000000085

Polanco, P. M., Mokdad, A. A., Zhu, H., Choti, M. A., & Huerta, S. (2018). Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and Resection. JAMA Oncol, 4(7), 938-943. doi:10.1001/jamaoncol.2018.0231

Practice & Guidelines - Gastrointestinal Cancer. Retrieved from https://www.asco.org/practice-guidelines/quality-guidelines/guidelines/gastrointestinal-cancer

Prasanna, T., Karapetis, C. S., Roder, D., Tie, J., Padbury, R., Price, T., . . . Yip, D. (2018). The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern. Acta Oncol, 57(11), 1438-1444. doi:10.1080/0284186x.2018.1487581

Prescribing, Recording and Reporting Photon Beam Therapy (Report 62). Retrieved from https://icru.org/home/reports/prescribing-recording-and-reporting-photon-beam-therapy-report-62

Prescribing, Recording, and Reporting Intensity-Modulated Photon-Beam Therapy (IMRT) (ICRU Report 83). Retrieved from https://icru.org/testing/reports/prescribing-recording-and-reporting-intensity-modulated-photon-beam-therapy-imrt-icru-report-83

Primrose, J. N., Perera, R., Gray, A., Rose, P., Fuller, A., Corkhill, A., . . . Investigators, F. T. (2014). Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA, 311(3), 263-270. doi:10.1001/jama.2013.285718

Ptok, H., Kube, R., Schmidt, U., Kockerling, F., Gastinger, I., & Lippert, H. (2009). Conversion from laparoscopic to open colonic cancer resection - associated factors and their influence on long-term oncological outcome. Eur J Surg Oncol, 35(12), 1273-1279. doi:10.1016/j.ejso.2009.06.006

Pålsson, B. (2017). Tidigare diagnostik för ökad överlevnad vid kolorektal cancer – förutsättningar för screening i Södra sjukvårdsregionen. Retrieved from Lund: 

Quenet, F., Elias, D., Roca, L., Goere, D., Ghouti, L., Pocard, M., . . . Glehen, O. (2018). A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. Journal of Clinical Oncology, 36(18_suppl), LBA3503-LBA3503. doi:10.1200/JCO.2018.36.18_suppl.LBA3503

Quirke, P., Durdey, P., Dixon, M. F., & Williams, N. S. (1986). Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet, 2(8514), 996-999. doi:10.1016/s0140-6736(86)92612-7

Quirke, P., & Morris, E. (2007). Reporting colorectal cancer. Histopathology, 50(1), 103-112. doi:10.1111/j.1365-2559.2006.02543.x

Quirke, P., Steele, R., Monson, J., Grieve, R., Khanna, S., Couture, J., . . . Sebag-Montefiore, D. (2009). Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet, 373(9666), 821-828. doi:10.1016/s0140-6736(09)60485-2

Rakic, A., Beaudry, P., & Mahoney, D. J. (2018). The complex interplay between neutrophils and cancer. Cell Tissue Res, 371(3), 517-529. doi:10.1007/s00441-017-2777-7

Reinwalds, M., Blixter, A., & Carlsson, E. (2017). A Descriptive, Qualitative Study to Assess Patient Experiences Following Stoma Reversal After Rectal Cancer Surgery. Ostomy Wound Manage, 63(12), 29-37. 

Reinwalds, M., Blixter, A., & Carlsson, E. (2018). Living with a resected rectum after rectal cancer surgery-Struggling not to let bowel function control life. J Clin Nurs, 27(3-4), e623-e634. doi:10.1111/jocn.14112

Renehan, A. G., Egger, M., Saunders, M. P., & O'Dwyer, S. T. (2002). Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ, 324(7341), 813. 

Renkonen-Sinisalo, L., Seppala, T. T., Jarvinen, H. J., & Mecklin, J. P. (2017). Subtotal Colectomy for Colon Cancer Reduces the Need for Subsequent Surgery in Lynch Syndrome. Dis Colon Rectum, 60(8), 792-799. doi:10.1097/dcr.0000000000000802

Ribeiro Gomes, J., Belotto, M., & D'Alpino Peixoto, R. (2017). The role of surgery for unusual sites of metastases from colorectal cancer: A review of the literature. Eur J Surg Oncol, 43(1), 15-19. doi:10.1016/j.ejso.2016.05.019

Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., . . . Gallinger, S. (2003). Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med, 349(3), 247-257. doi:10.1056/NEJMoa022289

Rock, C. L., Doyle, C., Demark-Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., . . . Gansler, T. (2012). Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin, 62(4), 243-274. doi:10.3322/caac.21142

Rodel, C., Graeven, U., Fietkau, R., Hohenberger, W., Hothorn, T., Arnold, D., . . . Liersch, T. (2015). Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol, 16(8), 979-989. doi:10.1016/s1470-2045(15)00159-x

Rombouts, A. J. M., Al-Najami, I., Abbott, N. L., Appelt, A., Baatrup, G., Bach, S., . . . de Wilt, J. H. W. (2017). Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study. BMJ Open, 7(12), e019474. doi:10.1136/bmjopen-2017-019474

Rosen, M., Chan, L., Beart, R. W., Jr., Vukasin, P., & Anthone, G. (1998). Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum, 41(9), 1116-1126. 

Roth, A. D., Delorenzi, M., Tejpar, S., Yan, P., Klingbiel, D., Fiocca, R., . . . Van Cutsem, E. (2012). Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer. J Natl Cancer Inst, 104(21), 1635-1646. doi:10.1093/jnci/djs427

Rouffet, F., Hay, J. M., Vacher, B., Fingerhut, A., Elhadad, A., Flamant, Y., . . . Gainant, A. (1994). Curative resection for left colonic carcinoma: hemicolectomy vs. segmental colectomy. A prospective, controlled, multicenter trial. French Association for Surgical Research. Dis Colon Rectum, 37(7), 651-659. doi:10.1007/bf02054407

Saglam, S., Bugra, D., Saglam, E. K., Asoglu, O., Balik, E., Yamaner, S., . . . Bulut, T. (2014). Fourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study. J Gastrointest Oncol, 5(1), 9-17. doi:10.3978/j.issn.2078-6891.2013.025

Sainato, A., Cernusco Luna Nunzia, V., Valentini, V., De Paoli, A., Maurizi, E. R., Lupattelli, M., . . . Cionini, L. (2014). No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT). Radiother Oncol, 113(2), 223-229. doi:10.1016/j.radonc.2014.10.006

Saltz, L. B., Clarke, S., Diaz-Rubio, E., Scheithauer, W., Figer, A., Wong, R., . . . Cassidy, J. (2008). Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol, 26(12), 2013-2019. doi:10.1200/JCO.2007.14.9930

Sarcher, T., Dupont, B., Alves, A., & Menahem, B. (2018). Anterior resection syndrome: What should we tell practitioners and patients in 2018? J Visc Surg, 155(5), 383-391. doi:10.1016/j.jviscsurg.2018.03.006

Sargent, D., Sobrero, A., Grothey, A., O'Connell, M. J., Buyse, M., Andre, T., . . . de Gramont, A. (2009). Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol, 27(6), 872-877. doi:10.1200/JCO.2008.19.5362

Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., . . . Gallinger, S. (2010). Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol, 28(20), 3219-3226. doi:10.1200/jco.2009.27.1825

Schmitz, K. H., Courneya, K. S., Matthews, C., Demark-Wahnefried, W., Galvao, D. A., Pinto, B. M., . . . Schwartz, A. L. (2010). American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc, 42(7), 1409-1426. doi:10.1249/MSS.0b013e3181e0c112

Schmoll, H.-J., Haustermans, K., Price, T. J., Nordlinger, B., Hofheinz, R., Daisne, J.-F., . . . Cutsem, E. V. (2018). Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine +/- oxaliplatin in locally advanced rectal cancer: Final results of PETACC-6. 36(15_suppl), 3500-3500. doi:10.1200/JCO.2018.36.15_suppl.3500

Schmoll, H. J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., . . . Cervantes, A. (2012). ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol, 23(10), 2479-2516. doi:10.1093/annonc/mds236

Scholin, J., Buunen, M., Hop, W., Bonjer, J., Anderberg, B., Cuesta, M., . . . Haglind, E. (2011). Bowel obstruction after laparoscopic and open colon resection for cancer: results of 5 years of follow-up in a randomized trial. Surg Endosc, 25(12), 3755-3760. doi:10.1007/s00464-011-1782-2

Schreuders, E. H., Ruco, A., Rabeneck, L., Schoen, R. E., Sung, J. J., Young, G. P., & Kuipers, E. J. (2015). Colorectal cancer screening: a global overview of existing programmes. Gut, 64(10), 1637-1649. doi:10.1136/gutjnl-2014-309086

Screening för tjock- och ändtarmscancer – Rekommendation och bedömningsunderlag. . (2014). Retrieved from http://www.socialstyrelsen.se/publikationer2014/2014-2-31

Sebag-Montefiore, D., Stephens, R. J., Steele, R., Monson, J., Grieve, R., Khanna, S., . . . Parmar, M. (2009). Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet, 373(9666), 811-820. doi:10.1016/s0140-6736(09)60484-0

Sebastian, S., Johnston, S., Geoghegan, T., Torreggiani, W., & Buckley, M. (2004). Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol, 99(10), 2051-2057. doi:10.1111/j.1572-0241.2004.40017.x

Segelman, J., Singnomklao, T., Hellborg, H., & Martling, A. (2009). Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer. Colorectal Dis, 11(7), 768-774. doi:10.1111/j.1463-1318.2008.01648.x

Segnan, N., Patnick, J., & von Karsa, L. (2010). European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: Office for Official Publications of the European Communities.

Sepulveda, A. R., Hamilton, S. R., Allegra, C. J., Grody, W., Cushman-Vokoun, A. M., Funkhouser, W. K., . . . Nowak, J. A. (2017a). Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology. J Clin Oncol, 35(13), 1453-1486. doi:10.1200/jco.2016.71.9807

Sepulveda, A. R., Hamilton, S. R., Allegra, C. J., Grody, W., Cushman-Vokoun, A. M., Funkhouser, W. K., . . . Nowak, J. A. (2017b). Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline Summary From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. J Oncol Pract, 13(5), 333-337. doi:10.1200/JOP.2017.022152

Seymour, M. T., Maughan, T. S., Ledermann, J. A., Topham, C., James, R., Gwyther, S. J., . . . National Cancer Research Institute Colorectal Clinical Studies, G. (2007). Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial. Lancet, 370(9582), 143-152. doi:10.1016/S0140-6736(07)61087-3

Shah, M. A., Renfro, L. A., Allegra, C. J., Andre, T., de Gramont, A., Schmoll, H. J., . . . Sargent, D. J. (2016). Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database. J Clin Oncol, 34(8), 843-853. doi:10.1200/jco.2015.63.0558

Shah, S. C., Day, L. W., Somsouk, M., & Sewell, J. L. (2013). Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther, 38(8), 925-934. doi:10.1111/apt.12479

Shahab, D., Gabriel, E., Attwood, K., Ma, W. W., Francescutti, V., Nurkin, S., & Boland, P. M. (2017). Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation. Clin Colorectal Cancer, 16(4), 300-307. doi:10.1016/j.clcc.2017.03.005

Sharp, L., Johansson, H., Hatschek, T., & Bergenmar, M. (2013). Smoking as an independent risk factor for severe skin reactions due to adjuvant radiotherapy for breast cancer. Breast, 22(5), 634-638. doi:10.1016/j.breast.2013.07.047

Shibata, D., Paty, P. B., Guillem, J. G., Wong, W. D., & Cohen, A. M. (2002). Surgical management of isolated retroperitoneal recurrences of colorectal carcinoma. Dis Colon Rectum, 45(6), 795-801. 

Sieber, O. M., Lipton, L., Crabtree, M., Heinimann, K., Fidalgo, P., Phillips, R. K., . . . Tomlinson, I. P. (2003). Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med, 348(9), 791-799. doi:10.1056/NEJMoa025283

Silver, J. K., & Baima, J. (2013). Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. Am J Phys Med Rehabil, 92(8), 715-727. doi:10.1097/PHM.0b013e31829b4afe

Simillis, C., Hompes, R., Penna, M., Rasheed, S., & Tekkis, P. P. (2016). A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery? Colorectal Dis, 18(1), 19-36. doi:10.1111/codi.13151

Simkens, L. H., van Tinteren, H., May, A., ten Tije, A. J., Creemers, G. J., Loosveld, O. J., . . . Koopman, M. (2015). Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group. Lancet, 385(9980), 1843-1852. doi:10.1016/s0140-6736(14)62004-3

Sinicrope, F. A., Shi, Q., Smyrk, T. C., Thibodeau, S. N., Dienstmann, R., Guinney, J., . . . Alberts, S. R. (2015). Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes. Gastroenterology, 148(1), 88-99. doi:10.1053/j.gastro.2014.09.041

Snowsill, T., Coelho, H., Huxley, N., Jones-Hughes, T., Briscoe, S., Frayling, I. M., & Hyde, C. (2017). Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation. Health Technol Assess, 21(51), 1-238. doi:10.3310/hta21510

Snyder, M., Bottiglieri, S., & Almhanna, K. (2018). Impact of Primary Tumor Location on First-line Bevacizumab or Cetuximab in Metastatic Colorectal Cancer. Rev Recent Clin Trials, 13(2), 139-149. doi:10.2174/1574887113666180328104109

Snyder, R. A., Hu, C. Y., Cuddy, A., Francescatti, A. B., Schumacher, J. R., Van Loon, K., . . . Chang, G. J. (2018). Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer. JAMA, 319(20), 2104-2115. doi:10.1001/jama.2018.5816

Socialdepartementet. (2015, 19 november, 2015). Träning ger färdighet. Koncentrera vården för patientens bästa Retrieved from https://www.regeringen.se/rattsliga-dokument/statens-offentliga-utredningar/2015/11/sou-201598/

Sondenaa, K., Quirke, P., Hohenberger, W., Sugihara, K., Kobayashi, H., Kessler, H., . . . Moran, B. (2014). The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference. Int J Colorectal Dis, 29(4), 419-428. doi:10.1007/s00384-013-1818-2

Sorbye, H., Pfeiffer, P., Cavalli-Bjorkman, N., Qvortrup, C., Holsen, M. H., Wentzel-Larsen, T., & Glimelius, B. (2009). Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients. Cancer, 115(20), 4679-4687. doi:10.1002/cncr.24527

Soveri, L. M., Lamminmaki, A., Hanninen, U. A., Karhunen, M., Bono, P., & Osterlund, P. (2019). Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy. Acta Oncol, 58(4), 398-406. doi:10.1080/0284186x.2018.1556804

Spada, C., Stoker, J., Alarcon, O., Barbaro, F., Bellini, D., Bretthauer, M., . . . Laghi, A. (2015). Clinical indications for computed tomographic colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline. Eur Radiol, 25(2), 331-345. doi:10.1007/s00330-014-3435-z

Statistik om dödsorsaker 2017. (2018). Retrieved from https://www.socialstyrelsen.se/sok/?q=statistik+om+d%C3%B6dsorsaker+2017

Steele, S. R., Chang, G. J., Hendren, S., Weiser, M., Irani, J., Buie, W. D., & Rafferty, J. F. (2015). Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer. Dis Colon Rectum, 58(8), 713-725. doi:10.1097/dcr.0000000000000410

Stefansson, M., & Nygren, P. (2016). Oxaliplatin added to fluoropyrimidine for adjuvant treatment of colorectal cancer is associated with long-term impairment of peripheral nerve sensory function and quality of life. Acta Oncol, 55(9-10), 1227-1235. doi:10.1080/0284186x.2016.1197420

Steinbach, G., Lynch, P. M., Phillips, R. K., Wallace, M. H., Hawk, E., Gordon, G. B., . . . Kelloff, G. (2000). The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med, 342(26), 1946-1952. doi:10.1056/NEJM200006293422603

Stewart, C. J., Hillery, S., Platell, C., & Puppa, G. (2011). Assessment of Serosal Invasion and Criteria for the Classification of Pathological (p) T4 Staging in Colorectal Carcinoma: Confusions, Controversies and Criticisms. Cancers (Basel), 3(1), 164-181. doi:10.3390/cancers3010164

Stevenson, A. R., Solomon, M. J., Lumley, J. W., Hewett, P., Clouston, A. D., Gebski, V. J., . . . Simes, J. (2015). Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial. JAMA, 314(13), 1356-1363. doi:10.1001/jama.2015.12009

Sugihara, K., Kobayashi, H., Kato, T., Mori, T., Mochizuki, H., Kameoka, S., . . . Muto, T. (2006). Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum, 49(11), 1663-1672. doi:10.1007/s10350-006-0714-z

Swank, H. A., Eshuis, E. J., Ubbink, D. T., & Bemelman, W. A. (2011). Is routine histopathological examination of appendectomy specimens useful? A systematic review of the literature. 13(11), 1214-1221. doi:10.1111/j.1463-1318.2010.02457.x

Swedish Rectal Cancer, T., Cedermark, B., Dahlberg, M., Glimelius, B., Pahlman, L., Rutqvist, L. E., & Wilking, N. (1997). Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med, 336(14), 980-987. doi:10.1056/NEJM199704033361402

Swellengrebel, H. A., Peters, E. G., Cats, A., Visser, O., Blaauwgeers, H. G., Verwaal, V. J., . . . Marijnen, C. A. (2011). Multidisciplinary discussion and management of rectal cancer: a population-based study. World J Surg, 35(9), 2125-2133. doi:10.1007/s00268-011-1181-9

Taieb, J., & et al. (2012). Adjuvant FOLFOX4 with or without cetuximab in patients with resected stage III colon cancer: DFS and overall survival results and subgroup analysis of the PETACC8 Intergroup phase III trial. . Ann Oncol. 

Taieb, J., Taly, V., Vernerey, D., Bourreau, C., Bennouna, J., Faroux, R., . . . Laurent-Puig, P. (2019). Analysis of circulating tumour DNA (ctDNA) from patients enrolled in the IDEA-FRANCE phase III trial: Prognostic and predictive value for adjuvant treatment duration. Annals of Oncology, 30, v867. doi:10.1093/annonc/mdz394.019

Tao, R., Tsai, C. J., Jensen, G., Eng, C., Kopetz, S., Overman, M. J., . . . Das, P. (2017). Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. Radiother Oncol, 122(1), 146-151. doi:10.1016/j.radonc.2016.12.015

Tejpar, S., Stintzing, S., Ciardiello, F., Tabernero, J., Van Cutsem, E., Beier, F., . . . Heinemann, V. (2016). Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials. JAMA Oncol. doi:10.1001/jamaoncol.2016.3797

Tejpar, S., Stintzing, S., Ciardiello, F., Tabernero, J., Van Cutsem, E., Beier, F., . . . Heinemann, V. (2017). Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials. JAMA Oncol, 3(2), 194-201. doi:10.1001/jamaoncol.2016.3797

Thorlacius, H. (2017). Riktlinjer för enoskopisk kontroll efter kolorektal polypektomi. Läkartidningen 2017; 114: EHD6.

Thorlacius, H., & Toth, E. (2018). Screening för kolorektal cancer – evidensläge, metoder och utmaningar. 2018;115:E3PI. 

Thyo, A., Emmertsen, K. J., & Laurberg, S. (2018). The Rectal Cancer Female Sexuality Score: Development and Validation of a Scoring System for Female Sexual Function After Rectal Cancer Surgery. Dis Colon Rectum, 61(6), 656-666. doi:10.1097/dcr.0000000000001064

Tidig upptäckt av symtomgivande cancer. En systematisk litteraturöversikt. Statens beredning för medicinsk utvärdering SBU-rapport nr 222 2014. Retrieved from https://www.sbu.se/sv/publikationer/SBU-utvarderar/tidig-upptackt-av-symtomgivande-cancer/

Titu, L. V., Tweedle, E., & Rooney, P. S. (2008). High tie of the inferior mesenteric artery in curative surgery for left colonic and rectal cancers: a systematic review. Dig Surg, 25(2), 148-157. doi:10.1159/000128172

Tonnesen, H., Nielsen, P. R., Lauritzen, J. B., & Moller, A. M. (2009). Smoking and alcohol intervention before surgery: evidence for best practice. Br J Anaesth, 102(3), 297-306. doi:10.1093/bja/aen401

Torring, M. L., Frydenberg, M., Hamilton, W., Hansen, R. P., Lautrup, M. D., & Vedsted, P. (2012). Diagnostic interval and mortality in colorectal cancer: U-shaped association demonstrated for three different datasets. J Clin Epidemiol, 65(6), 669-678. doi:10.1016/j.jclinepi.2011.12.006

Torring, M. L., Frydenberg, M., Hansen, R. P., Olesen, F., & Vedsted, P. (2013). Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur J Cancer, 49(9), 2187-2198. doi:10.1016/j.ejca.2013.01.025

Tournigand, C., Andre, T., Bonnetain, F., Chibaudel, B., Lledo, G., Hickish, T., . . . de Gramont, A. (2012). Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. J Clin Oncol, 30(27), 3353-3360. doi:10.1200/JCO.2012.42.5645

Traa, M. J., De Vries, J., Roukema, J. A., & Den Oudsten, B. L. (2012). Sexual (dys)function and the quality of sexual life in patients with colorectal cancer: a systematic review. Ann Oncol, 23(1), 19-27. doi:10.1093/annonc/mdr133

Transanal Total Mesorectal Excision. Retrieved from https://tatme.medicaldata.eu

Treasure, T., Monson, K., Fiorentino, F., & Russell, C. (2014). The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer. BMJ Open, 4(5), e004385. doi:10.1136/bmjopen-2013-004385

Truta, B., Chen, Y. Y., Blanco, A. M., Deng, G., Conrad, P. G., Kim, Y. H., . . . Terdiman, J. P. (2008). Tumor histology helps to identify Lynch syndrome among colorectal cancer patients. Fam Cancer, 7(3), 267-274. doi:10.1007/s10689-008-9186-8

Turner, R. R., Steed, L., Quirk, H., Greasley, R. U., Saxton, J. M., Taylor, S. J., . . . Bourke, L. (2018). Interventions for promoting habitual exercise in people living with and beyond cancer. Cochrane Database Syst Rev, 9, Cd010192. doi:10.1002/14651858.CD010192.pub3

Tveit, K. M., Guren, T., Glimelius, B., Pfeiffer, P., Sorbye, H., Pyrhonen, S., . . . Christoffersen, T. (2012). Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study. J Clin Oncol, 30(15), 1755-1762. doi:10.1200/JCO.2011.38.0915

Twelves, C., Wong, A., Nowacki, M. P., Abt, M., Burris, H., 3rd, Carrato, A., . . . Scheithauer, W. (2005). Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med, 352(26), 2696-2704. doi:10.1056/NEJMoa043116

Törnberg, S., Lundström, V., Gustafsson, S., & Hultkrantz, R. (2010). Första året med kolorektalcancerscreening i Stockholm. Noggrann monitorering och kvalitetskontroll nödvändigt. Lakartidningen, 107, 1709-1711. 

Ueno, M., Oya, M., Azekura, K., Yamaguchi, T., & Muto, T. (2005). Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg, 92(6), 756-763. doi:10.1002/bjs.4975

Vale, C. L., Tierney, J. F., Fisher, D., Adams, R. A., Kaplan, R., Maughan, T. S., . . . Meade, A. M. (2012). Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis. Cancer Treat Rev, 38(6), 618-625. doi:10.1016/j.ctrv.2011.11.002

Valentini, V., Gambacorta, M. A., Barbaro, B., Chiloiro, G., Coco, C., Das, P., . . . Haustermans, K. (2016). International consensus guidelines on Clinical Target Volume delineation in rectal cancer. Radiother Oncol, 120(2), 195-201. doi:10.1016/j.radonc.2016.07.017

Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., . . . Arnold, D. (2016). ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol, 27(8), 1386-1422. doi:10.1093/annonc/mdw235

Van Cutsem, E., Cervantes, A., Nordlinger, B., Arnold, D., & Group, E. G. W. (2014). Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 25 Suppl 3, iii1-9. doi:10.1093/annonc/mdu260

Van Cutsem, E., Peeters, M., Siena, S., Humblet, Y., Hendlisz, A., Neyns, B., . . . Amado, R. G. (2007). Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol, 25(13), 1658-1664. doi:10.1200/jco.2006.08.1620

van der Pas, M., Deijen, C. L., Abis, G. S. A., de Lange-de Klerk, E. S. M., Haglind, E., Furst, A., . . . Bonjer, H. J. (2017). Conversions in laparoscopic surgery for rectal cancer. Surg Endosc, 31(5), 2263-2270. doi:10.1007/s00464-016-5228-8

van der Pas, M. H., Haglind, E., Cuesta, M. A., Furst, A., Lacy, A. M., Hop, W. C., . . . Group, C. O. c. L. o. O. R. I. S. (2013). Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol, 14(3), 210-218. doi:10.1016/S1470-2045(13)70016-0

van der Valk, M. J. M., Hilling, D. E., Bastiaannet, E., Meershoek-Klein Kranenbarg, E., Beets, G. L., Figueiredo, N. L., . . . van de Velde, C. J. H. (2018). Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet, 391(10139), 2537-2545. doi:10.1016/s0140-6736(18)31078-x

van Gijn, W., Marijnen, C. A., Nagtegaal, I. D., Kranenbarg, E. M., Putter, H., Wiggers, T., . . . Dutch Colorectal Cancer, G. (2011). Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol, 12(6), 575-582. doi:10.1016/S1470-2045(11)70097-3

van Hooft, J. E., Bemelman, W. A., Oldenburg, B., Marinelli, A. W., Lutke Holzik, M. F., Grubben, M. J., . . . collaborative Dutch Stent-In study, g. (2011). Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial. Lancet Oncol, 12(4), 344-352. doi:10.1016/S1470-2045(11)70035-3

van Hooft, J. E., van Halsema, E. E., Vanbiervliet, G., Beets-Tan, R. G., DeWitt, J. M., Donnellan, F., . . . European Society of Gastrointestinal, E. (2014). Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Gastrointest Endosc, 80(5), 747-761 e741-775. doi:10.1016/j.gie.2014.09.018

Wang, P., Zhou, S., Zhou, H., Liang, J., & Zhou, Z. (2019). Evaluating predictive factors for determining the presence of lateral pelvic node metastasis in rectal cancer patients following neoadjuvant chemoradiotherapy. Colorectal Dis. doi:10.1111/codi.14595

Wang, Y., Zhou, M., Yang, J., Sun, X., Zou, W., Zhang, Z., . . . Zhang, Z. (2019). Increased lymph node yield indicates improved survival in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Cancer Med, 8(10), 4615-4625. doi:10.1002/cam4.2372

Watanabe, T., Tsurita, G., Muto, T., Sawada, T., Sunouchi, K., Higuchi, Y., . . . Nagawa, H. (2002). Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. Surgery, 132(1), 27-33. 

Watch and Wait as Treatment for Patients With Rectal Cancer (WoW). (August 31, 2018). Retrieved from https://clinicaltrials.gov/ct2/show/NCT03125343

Watson, P., Ashwathnarayan, R., Lynch, H. T., & Roy, H. K. (2004). Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). Arch Intern Med, 164(22), 2429-2431. doi:10.1001/archinte.164.22.2429

Webber, E. M., Kauffman, T. L., O'Connor, E., & Goddard, K. A. (2015). Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy. BMC Cancer, 15, 156. doi:10.1186/s12885-015-1093-4

Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hubner, M., Klek, S., . . . Singer, P. (2017). ESPEN guideline: Clinical nutrition in surgery. Clin Nutr, 36(3), 623-650. doi:10.1016/j.clnu.2017.02.013

Veldkamp, R., Kuhry, E., Hop, W. C., Jeekel, J., Kazemier, G., Bonjer, H. J., . . . Group, C. O. c. L. o. O. R. S. (2005). Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol, 6(7), 477-484. doi:10.1016/S1470-2045(05)70221-7

Wells, M., Macmillan, M., Raab, G., MacBride, S., Bell, N., MacKinnon, K., . . . Munro, A. (2004). Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiother Oncol, 73(2), 153-162. doi:10.1016/j.radonc.2004.07.032

Venderbosch, S., Doornebal, J., Teerenstra, S., Lemmens, W., Punt, C. J., & Koopman, M. (2012). Outcome of first line systemic treatment in elderly compared to younger patients with metastatic colorectal cancer: a retrospective analysis of the CAIRO and CAIRO2 studies of the Dutch Colorectal Cancer Group (DCCG). Acta Oncol, 51(7), 831-839. doi:10.3109/0284186x.2012.699193

Venook, A. P., Niedzwiecki, D., Innocenti, F., Fruth, B., Greene, C., O'Neil, B. H., . . . Lenz, H.-J. (2016). Impact of primary (1º) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance). 34(15_suppl), 3504-3504. doi:10.1200/JCO.2016.34.15_suppl.3504

Venook, A. P., Niedzwiecki, D., Lenz, H.-J., Innocenti, F., Mahoney, M. R., O'Neil, B. H., . . . ECOG. (2014). CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC). 32(15_suppl), LBA3-LBA3. doi:10.1200/jco.2014.32.15_suppl.lba3

Verberne, C. J., Zhan, Z., van den Heuvel, E., Grossmann, I., Doornbos, P. M., Havenga, K., . . . Wiggers, T. (2015). Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized "CEAwatch" trial. Eur J Surg Oncol, 41(9), 1188-1196. doi:10.1016/j.ejso.2015.06.008

West, N. P., Sutton, K. M., Ingeholm, P., Hagemann-Madsen, R. H., Hohenberger, W., & Quirke, P. (2010). Improving the quality of colon cancer surgery through a surgical education program. Dis Colon Rectum, 53(12), 1594-1603. doi:10.1007/DCR.0b013e3181f433e3

Whiteford, M. H., Denk, P. M., & Swanstrom, L. L. (2007). Feasibility of radical sigmoid colectomy performed as natural orifice translumenal endoscopic surgery (NOTES) using transanal endoscopic microsurgery. Surg Endosc, 21(10), 1870-1874. doi:10.1007/s00464-007-9552-x

Vigorita, V., Rausei, S., Troncoso Pereira, P., Trostchansky, I., Ruano Poblador, A., Moncada Iribarren, E., . . . Casal Nunez, E. (2017). A pilot study assessing the efficacy of posterior tibial nerve stimulation in the treatment of low anterior resection syndrome. Tech Coloproctol, 21(4), 287-293. doi:10.1007/s10151-017-1608-x

Wille-Jorgensen, P., Laurberg, S., Pahlman, L., Carriquiry, L., Lundqvist, N., Smedh, K., . . . Bengtson, J. (2009). An interim analysis of recruitment to the COLOFOL trial. Colorectal Dis, 11(7), 756-758. 

Wille-Jorgensen, P., Syk, I., Smedh, K., Laurberg, S., Nielsen, D. T., Petersen, S. H., . . . Sorensen, H. T. (2018). Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial. JAMA, 319(20), 2095-2103. doi:10.1001/jama.2018.5623

Wilson, J. M. G., Junger, G. (1968). Principles and practice of screening for disease Genève: WHO: Public Health Papers 34.

Wiltink, L. M., Nout, R. A., Fiocco, M., Meershoek-Klein Kranenbarg, E., Jurgenliemk-Schulz, I. M., Jobsen, J. J., . . . Marijnen, C. A. (2015). No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials. J Clin Oncol, 33(15), 1640-1646. doi:10.1200/jco.2014.58.6693

Win, A. K., Dowty, J. G., Antill, Y. C., English, D. R., Baron, J. A., Young, J. P., . . . Jenkins, M. A. (2011). Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers. Obstet Gynecol, 117(4), 899-905. doi:10.1097/AOG.0b013e3182110ea3

Win, A. K., Dowty, J. G., English, D. R., Campbell, P. T., Young, J. P., Winship, I., . . . Jenkins, M. A. (2011). Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes. Br J Cancer, 105(1), 162-169. doi:10.1038/bjc.2011.172

Winther, S. B., Liposits, G., Skuladottir, H., Hofsli, E., Shah, C. H., Poulsen, L. O., . . . Pfeiffer, P. (2019). Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial. Lancet Gastroenterol Hepatol, 4(5), 376-388. doi:10.1016/s2468-1253(19)30041-x

Wolmark, N., Rockette, H., Mamounas, E., Jones, J., Wieand, S., Wickerham, D. L., . . . Fisher, B. (1999). Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. J Clin Oncol, 17(11), 3553-3559. doi:10.1200/jco.1999.17.11.3553

von Renteln, D., & Pohl, H. (2017). Polyp Resection - Controversial Practices and Unanswered Questions. Clin Transl Gastroenterol, 8(3), e76. doi:10.1038/ctg.2017.6

Wonders, K. Y., & Stout, B. The Role of Exercise in Chemotherapy-Induced Peripheral Neuropathy. In.

Wong, J. S., Tan, G. H., & Teo, M. C. (2016). Management of para-aortic lymph node metastasis in colorectal patients: A systemic review. Surg Oncol, 25(4), 411-418. doi:10.1016/j.suronc.2016.09.008

Wåhlin, S. (2015). Alkohol : en fråga för oss i vården. Lund: Studentlitteratur.

Vårdhandboken. Energi-, närings- och vätskebehov. Retrieved from https://www.vardhandboken.se/vard-och-behandling/nutrition/nutrition/energi--narings--och-vatskebehov/

Vårdhandboken. Munhälsa. Retrieved from https://www.vardhandboken.se/sok/?q=munh%C3%A4lsa

Vårdhandboken. Riskidentifiering och riskbedömning/ Behandlingsplan. Retrieved from https://www.vardhandboken.se/vard-och-behandling/nutrition/nutrition/behandlingvardplan/

Xu, W., Xu, Z., Cheng, H., Ying, J., Cheng, F., Xu, W., . . . Luo, J. (2016). Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis. Eur J Surg Oncol, 42(12), 1841-1850. doi:10.1016/j.ejso.2016.09.002

Yamada, K., Tsukamoto, S., Ochiai, H., Shida, D., & Kanemitsu, Y. (2018). Improving Selection for Resection of Synchronous Para-Aortic Lymph Node Metastases in Colorectal Cancer. Dig Surg, 1-7. doi:10.1159/000491100

Yamashita, T., Kato, K., Long, N. K., Makita, H., Yonemoto, K., Iida, K., . . . Shibata, T. (2014). Effects of smoking and alcohol consumption on 5-fluorouracil-related metabolic enzymes in oral squamous cell carcinoma. Mol Clin Oncol, 2(3), 429-434. doi:10.3892/mco.2014.267

Yan, T. D., Black, D., Savady, R., & Sugarbaker, P. H. (2007). A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol, 14(2), 484-492. doi:10.1245/s10434-006-9182-x

Yde, J., Larsen, H. M., Laurberg, S., Krogh, K., & Moeller, H. B. (2018). Chronic diarrhoea following surgery for colon cancer-frequency, causes and treatment options. Int J Colorectal Dis, 33(6), 683-694. doi:10.1007/s00384-018-2993-y

Ye, Y. J., Shen, Z. L., Sun, X. T., Wang, Z. F., Shen, D. H., Liu, H. J., . . . Wang, S. (2012). Impact of multidisciplinary team working on the management of colorectal cancer. Chin Med J (Engl), 125(2), 172-177. 

Yoshino, T., Mizunuma, N., Yamazaki, K., Nishina, T., Komatsu, Y., Baba, H., . . . Ohtsu, A. (2012). TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol, 13(10), 993-1001. doi:10.1016/s1470-2045(12)70345-5

Yothers, G., O'Connell, M. J., Allegra, C. J., Kuebler, J. P., Colangelo, L. H., Petrelli, N. J., & Wolmark, N. (2011). Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol, 29(28), 3768-3774. doi:10.1200/JCO.2011.36.4539

Yuhara, H., Steinmaus, C., Cohen, S. E., Corley, D. A., Tei, Y., & Buffler, P. A. (2011). Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol, 106(11), 1911-1921; quiz 1922. doi:10.1038/ajg.2011.301

Zhao, L., Liu, R., Zhang, Z., Li, T., Li, F., Liu, H., & Li, G. (2016). Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials. Colorectal Dis, 18(8), 763-772. doi:10.1111/codi.13381

 

Nästa kapitel
24 Vårdprogramgruppen